ONTOLOGY REPORT - ANNOTATIONS
| Term: | methotrexate |
|
| Accession: | CHEBI:44185
|
browse the term
|
| Definition: | A pteridine that has formula C20H22N8O5. |
| Synonyms: | exact_synonym: | N-(4-{[(2,4-diaminopteridin-6-yl)methyl](methyl)amino}benzoyl)-L-glutamic acid |
| | related_synonym: | 4-amino-10-methylfolic acid; 4-amino-N(10)-methylpteroylglutamic acid; C20H22N8O5; CN(Cc1cnc2nc(N)nc(N)c2n1)c1ccc(cc1)C(=O)N[C@@H](CCC(O)=O)C(O)=O; Emtexate; InChI=1S/C20H22N8O5/c1-28(9-11-8-23-17-15(24-11)16(21)26-20(22)27-17)12-4-2-10(3-5-12)18(31)25-13(19(32)33)6-7-14(29)30/h2-5,8,13H,6-7,9H2,1H3,(H,25,31)(H,29,30)(H,32,33)(H4,21,22,23,26,27)/t13-/m0/s1; InChIKey=FBOZXECLQNJBKD-ZDUSSCGKSA-N; Ledertrexate; MTX; N-[(4-{[(2,4-diaminopteridin-6-yl)methyl](methyl)amino}phenyl)carbonyl]-L-glutamic acid; N-[4-[[(2,4-diamino-6-pteridinyl)methyl]methylamino]benzoyl]-L-glutamic acid; Rheumatrex; Trexall; methotrexatum; metotrexato |
| | alt_id: | CHEBI:44183; CHEBI:6837 |
| | xref_casrn: | 59-05-2 |
| | xref: | Beilstein:70669 "Beilstein Registry Number"; ChEMBL:149931 "ChEMBL COMPOUND"; ChemIDplus:59-05-2 "CAS Registry Number"; DrugBank:DB00563 "DrugBank"; KEGG COMPOUND:59-05-2 "CAS Registry Number"; KEGG COMPOUND:C01937 "KEGG COMPOUND"; KEGG DRUG:D00142 "KEGG DRUG" |
| | xref_mesh: | MESH:D008727 |
| | xref: | NIST Chemistry WebBook:59-05-2 "CAS Registry Number"; PDBeChem:MTX "PDBeChem"; Patent:US2512572 "Patent"; Wikipedia:Methotrexate "Wikipedia" |
| | cyclic_relationship: | is_conjugate_acid_of CHEBI:50680 |
|
|
methotrexate
|
| G |
Abcb1a |
ATP-binding cassette, sub-family B (MDR/TAP), member 1A |
|
increases response to substance |
ISO |
4 |
21,709,855 |
21,796,628 |
RGD:6480464 |
CTD |
| G |
Abcb1a |
ATP-binding cassette, sub-family B (MDR/TAP), member 1A |
|
multiple interactions |
ISO |
4 |
21,709,855 |
21,796,628 |
RGD:6480464 |
CTD |
| G |
Abcb1a |
ATP-binding cassette, sub-family B (MDR/TAP), member 1A |
|
multiple interactions |
ISO |
4 |
21,709,855 |
21,796,628 |
RGD:6480464 |
CTD |
| G |
Abcb1a |
ATP-binding cassette, sub-family B (MDR/TAP), member 1A |
|
increases expression |
ISO |
4 |
21,709,855 |
21,796,628 |
RGD:6480464 |
CTD |
| G |
Abcb1b |
ATP-binding cassette, subfamily B (MDR/TAP), member 1B |
|
affects expression |
ISO |
4 |
21,829,489 |
21,912,239 |
RGD:6480464 |
CTD |
| G |
Abcc1 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 1 |
|
affects transport |
ISO |
10 |
452,239 |
575,705 |
RGD:6480464 |
CTD |
| G |
Abcc1 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 1 |
|
increases transport |
EXP |
10 |
452,239 |
575,705 |
RGD:6480464 |
CTD |
| G |
Abcc2 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 2 |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Abcc2 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 2 |
|
increases response to substance |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Abcc2 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 2 |
|
affects transport |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Abcc2 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 2 |
|
decreases response to substance |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Abcc2 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 2 |
|
increases response to substance |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Abcc2 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 2 |
|
multiple interactions |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Abcc2 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 2 |
|
increases export |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Abcc2 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 2 |
|
decreases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Abcc2 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 2 |
|
increases import |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Abcc4 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 4 |
|
multiple interactions |
ISO |
15 |
103,384,848 |
103,611,238 |
RGD:6480464 |
CTD |
| G |
Abcc4 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 4 |
|
multiple interactions |
ISO |
15 |
103,384,848 |
103,611,238 |
RGD:6480464 |
CTD |
| G |
Abcc4 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 4 |
|
increases transport |
ISO |
15 |
103,384,848 |
103,611,238 |
RGD:6480464 |
CTD |
| G |
Abcg2 |
ATP-binding cassette, subfamily G (WHITE), member 2 |
|
increases transport |
ISO |
4 |
87,502,584 |
87,560,017 |
RGD:6480464 |
CTD |
| G |
Abcg2 |
ATP-binding cassette, subfamily G (WHITE), member 2 |
|
multiple interactions |
ISO |
4 |
87,502,584 |
87,560,017 |
RGD:6480464 |
CTD |
| G |
Abcg2 |
ATP-binding cassette, subfamily G (WHITE), member 2 |
|
affects transport |
ISO |
4 |
87,502,584 |
87,560,017 |
RGD:6480464 |
CTD |
| G |
Abcg2 |
ATP-binding cassette, subfamily G (WHITE), member 2 |
|
affects response to substance |
ISO |
4 |
87,502,584 |
87,560,017 |
RGD:6480464 |
CTD |
| G |
Abcg2 |
ATP-binding cassette, subfamily G (WHITE), member 2 |
|
multiple interactions |
ISO |
4 |
87,502,584 |
87,560,017 |
RGD:6480464 |
CTD |
| G |
Abcg2 |
ATP-binding cassette, subfamily G (WHITE), member 2 |
|
increases transport |
EXP |
4 |
87,502,584 |
87,560,017 |
RGD:6480464 |
CTD |
| G |
Abcg4 |
ATP-binding cassette, subfamily G (WHITE), member 4 |
|
affects expression |
ISO |
8 |
47,251,688 |
47,267,439 |
RGD:6480464 |
CTD |
| G |
Abhd2 |
abhydrolase domain containing 2 |
|
affects expression |
ISO |
1 |
135,025,144 |
135,111,792 |
RGD:6480464 |
CTD |
| G |
Abp1 |
amiloride binding protein 1 (amine oxidase, copper-containing) |
|
affects response to substance |
ISO |
4 |
76,957,477 |
76,977,643 |
RGD:6480464 |
CTD |
| G |
Acaa1a |
acetyl-Coenzyme A acyltransferase 1A |
|
decreases expression |
EXP |
8 |
124,305,097 |
124,313,887 |
RGD:6480464 |
CTD |
| G |
Acaa2 |
acetyl-CoA acyltransferase 2 |
|
affects expression |
ISO |
18 |
71,587,259 |
71,632,610 |
RGD:6480464 |
CTD |
| G |
Acer2 |
alkaline ceramidase 2 |
|
increases expression |
EXP |
5 |
106,185,779 |
106,237,588 |
RGD:6480464 |
CTD |
| G |
Aco2 |
aconitase 2, mitochondrial |
|
affects expression |
ISO |
7 |
120,223,788 |
120,266,944 |
RGD:6480464 |
CTD |
| G |
Acot3 |
acyl-CoA thioesterase 3 |
|
affects expression |
ISO |
6 |
108,089,349 |
108,095,288 |
RGD:6480464 |
CTD |
| G |
Acot4 |
acyl-CoA thioesterase 4 |
|
affects expression |
ISO |
6 |
108,075,508 |
108,080,792 |
RGD:6480464 |
CTD |
| G |
Acox1 |
acyl-CoA oxidase 1, palmitoyl |
|
decreases expression |
EXP |
10 |
106,281,977 |
106,319,382 |
RGD:6480464 |
CTD |
| G |
Acpp |
acid phosphatase, prostate |
|
decreases expression |
EXP |
8 |
109,354,381 |
109,400,296 |
RGD:6480464 |
CTD |
| G |
Actg1 |
actin, gamma 1 |
|
affects expression |
ISO |
10 |
109,773,489 |
109,776,334 |
RGD:6480464 |
CTD |
| G |
Actr1a |
ARP1 actin-related protein 1 homolog A, centractin alpha (yeast) |
|
affects response to substance |
ISO |
1 |
251,592,429 |
251,611,097 |
RGD:6480464 |
CTD |
| G |
Acvr1b |
activin A receptor, type IB |
|
affects expression |
ISO |
7 |
139,910,157 |
139,958,740 |
RGD:6480464 |
CTD |
| G |
Ada |
adenosine deaminase |
|
multiple interactions |
EXP |
3 |
154,636,530 |
154,660,637 |
RGD:6480464 |
CTD |
| G |
Ada |
adenosine deaminase |
|
increases activity |
EXP |
3 |
154,636,530 |
154,660,637 |
RGD:6480464 |
CTD |
| G |
Adamts5 |
ADAM metallopeptidase with thrombospondin type 1 motif, 5 |
|
affects expression |
ISO |
11 |
25,503,380 |
25,548,851 |
RGD:6480464 |
CTD |
| G |
Adat1 |
adenosine deaminase, tRNA-specific 1 |
|
affects expression |
ISO |
19 |
41,902,820 |
41,926,545 |
RGD:6480464 |
CTD |
| G |
Adcy7 |
adenylate cyclase 7 |
|
affects expression |
ISO |
19 |
20,051,639 |
20,073,861 |
RGD:6480464 |
CTD |
| G |
Adcyap1 |
adenylate cyclase activating polypeptide 1 |
|
affects expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Adhfe1 |
alcohol dehydrogenase, iron containing, 1 |
|
affects expression |
ISO |
5 |
9,276,929 |
9,303,483 |
RGD:6480464 |
CTD |
| G |
Adora2a |
adenosine A2a receptor |
|
increases expression |
EXP |
20 |
13,815,719 |
13,834,131 |
RGD:6480464 |
CTD |
| G |
Adora3 |
adenosine A3 receptor |
|
increases expression |
ISO |
2 |
201,157,782 |
201,161,425 |
RGD:6480464 |
CTD |
| G |
Adora3 |
adenosine A3 receptor |
|
increases expression |
EXP |
2 |
201,157,782 |
201,161,425 |
RGD:6480464 |
CTD |
| G |
Ago4 |
argonaute RISC catalytic component 4 |
|
affects expression |
ISO |
5 |
145,857,594 |
145,902,950 |
RGD:6480464 |
CTD |
| G |
Ago4 |
argonaute RISC catalytic component 4 |
|
affects expression |
ISO |
5 |
145,857,594 |
145,902,950 |
RGD:6480464 |
CTD |
| G |
Agt |
angiotensinogen (serpin peptidase inhibitor, clade A, member 8) |
|
affects expression |
ISO |
19 |
54,738,556 |
54,750,349 |
RGD:6480464 |
CTD |
| G |
Ahctf1 |
AT hook containing transcription factor 1 |
|
affects expression |
ISO |
13 |
95,432,560 |
95,483,323 |
RGD:6480464 |
CTD |
| G |
Ahcy |
adenosylhomocysteinase |
|
affects expression |
ISO |
3 |
145,544,834 |
145,560,058 |
RGD:6480464 |
CTD |
| G |
Ahsp |
alpha hemoglobin stabilizing protein |
|
affects expression |
ISO |
1 |
187,560,690 |
187,561,662 |
RGD:6480464 |
CTD |
| G |
Aim2 |
absent in melanoma 2 |
|
affects response to substance |
ISO |
13 |
89,631,797 |
89,640,265 |
RGD:6480464 |
CTD |
| G |
Aimp2 |
aminoacyl tRNA synthetase complex-interacting multifunctional protein 2 |
|
affects expression |
ISO |
12 |
11,028,968 |
11,038,458 |
RGD:6480464 |
CTD |
| G |
Akr1e2 |
aldo-keto reductase family 1, member E2 |
|
affects expression |
ISO |
17 |
77,011,336 |
77,025,824 |
RGD:6480464 |
CTD |
| G |
Alas1 |
aminolevulinate, delta-, synthase 1 |
|
affects expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Alas2 |
aminolevulinate, delta-, synthase 2 |
|
decreases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Alb |
albumin |
|
decreases expression |
EXP |
14 |
19,126,935 |
19,142,214 |
RGD:6480464 |
CTD |
| G |
Alox12 |
arachidonate 12-lipoxygenase |
|
decreases expression |
EXP |
10 |
57,080,603 |
57,092,874 |
RGD:6480464 |
CTD |
| G |
Alox5 |
arachidonate 5-lipoxygenase |
|
affects response to substance |
ISO |
4 |
152,610,283 |
152,657,891 |
RGD:6480464 |
CTD |
| G |
Alpi |
alkaline phosphatase, intestinal |
|
multiple interactions |
ISO |
9 |
85,892,887 |
85,896,353 |
RGD:6480464 |
CTD |
| G |
Alpi |
alkaline phosphatase, intestinal |
|
increases activity |
ISO |
9 |
85,892,887 |
85,896,353 |
RGD:6480464 |
CTD |
| G |
Alpp |
alkaline phosphatase, placental |
|
affects response to substance |
ISO |
9 |
85,885,336 |
85,888,082 |
RGD:6480464 |
CTD |
| G |
Alppl2 |
alkaline phosphatase, placental-like 2 |
|
affects expression |
ISO |
9 |
85,873,702 |
85,876,375 |
RGD:6480464 |
CTD |
| G |
Als2cr8 |
amyotrophic lateral sclerosis 2 (juvenile) chromosome region, candidate 8 |
|
affects expression |
ISO |
9 |
58,642,178 |
58,689,313 |
RGD:6480464 |
CTD |
| G |
Anapc1 |
anaphase promoting complex subunit 1 |
|
affects expression |
ISO |
3 |
116,212,111 |
116,299,282 |
RGD:6480464 |
CTD |
| G |
Ankrd10 |
ankyrin repeat domain 10 |
|
affects expression |
ISO |
16 |
82,719,075 |
82,742,218 |
RGD:6480464 |
CTD |
| G |
Ankrd22 |
ankyrin repeat domain 22 |
|
affects expression |
ISO |
1 |
237,986,215 |
238,017,941 |
RGD:6480464 |
CTD |
| G |
Ankrd6 |
ankyrin repeat domain 6 |
|
affects expression |
ISO |
5 |
49,098,952 |
49,211,771 |
RGD:6480464 |
CTD |
| G |
Anpep |
alanyl (membrane) aminopeptidase |
|
increases expression |
ISO |
1 |
135,600,751 |
135,619,208 |
RGD:6480464 |
CTD |
| G |
Anxa11 |
annexin A11 |
|
affects response to substance |
ISO |
16 |
1,449,907 |
1,496,053 |
RGD:6480464 |
CTD |
| G |
Aox1 |
aldehyde oxidase 1 |
|
affects metabolic processing |
ISO |
9 |
56,693,698 |
56,774,115 |
RGD:6480464 |
CTD |
| G |
Ap1g1 |
adaptor-related protein complex 1, gamma 1 subunit |
|
affects expression |
ISO |
19 |
39,676,021 |
39,734,854 |
RGD:6480464 |
CTD |
| G |
Ap3s1 |
adaptor-related protein complex 3, sigma 1 subunit |
|
affects expression |
ISO |
18 |
40,944,324 |
41,016,397 |
RGD:6480464 |
CTD |
| G |
Apbb1 |
amyloid beta (A4) precursor protein-binding, family B, member 1 (Fe65) |
|
affects expression |
ISO |
1 |
163,282,918 |
163,299,333 |
RGD:6480464 |
CTD |
| G |
Aplp1 |
amyloid beta (A4) precursor-like protein 1 |
|
affects expression |
ISO |
1 |
85,390,217 |
85,401,952 |
RGD:6480464 |
CTD |
| G |
Apod |
apolipoprotein D |
|
affects expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Apof |
apolipoprotein F |
|
affects expression |
ISO |
7 |
1,562,515 |
1,563,953 |
RGD:6480464 |
CTD |
| G |
Arfip1 |
ADP-ribosylation factor interacting protein 1 |
|
affects response to substance |
ISO |
2 |
176,275,425 |
176,353,675 |
RGD:6480464 |
CTD |
| G |
Arhgap10 |
Rho GTPase activating protein 10 |
|
affects expression |
ISO |
19 |
32,261,771 |
32,521,913 |
RGD:6480464 |
CTD |
| G |
Arhgap24 |
Rho GTPase activating protein 24 |
|
affects expression |
ISO |
14 |
8,026,238 |
8,075,033 |
RGD:6480464 |
CTD |
| G |
Arhgdia |
Rho GDP dissociation inhibitor (GDI) alpha |
|
affects response to substance |
ISO |
10 |
109,967,771 |
109,971,260 |
RGD:6480464 |
CTD |
| G |
Arid1a |
AT rich interactive domain 1A (SWI-like) |
|
affects expression |
ISO |
5 |
151,355,617 |
151,398,647 |
RGD:6480464 |
CTD |
| G |
Arl6ip4 |
ADP-ribosylation-like factor 6 interacting protein 4 |
|
affects response to substance |
ISO |
12 |
33,603,784 |
33,605,929 |
RGD:6480464 |
CTD |
| G |
Arnt |
aryl hydrocarbon receptor nuclear translocator |
|
affects expression |
ISO |
2 |
190,333,978 |
190,391,015 |
RGD:6480464 |
CTD |
| G |
Arntl |
aryl hydrocarbon receptor nuclear translocator-like |
|
affects expression |
ISO |
1 |
171,062,181 |
171,162,426 |
RGD:6480464 |
CTD |
| G |
Arntl |
aryl hydrocarbon receptor nuclear translocator-like |
|
decreases expression |
EXP |
1 |
171,062,181 |
171,162,426 |
RGD:6480464 |
CTD |
| G |
Asb12 |
ankyrin repeat and SOCS box-containing 12 |
|
affects expression |
ISO |
X |
83,013,812 |
83,102,298 |
RGD:6480464 |
CTD |
| G |
Asb7 |
ankyrin repeat and SOCS box-containing 7 |
|
affects expression |
ISO |
1 |
121,091,586 |
121,142,773 |
RGD:6480464 |
CTD |
| G |
Asl |
argininosuccinate lyase |
|
affects expression |
ISO |
12 |
27,702,882 |
27,720,230 |
RGD:6480464 |
CTD |
| G |
Ass1 |
argininosuccinate synthase 1 |
|
increases expression |
EXP |
3 |
10,578,717 |
10,622,332 |
RGD:6480464 |
CTD |
| G |
Atf3 |
activating transcription factor 3 |
|
affects expression |
ISO |
13 |
107,191,622 |
107,223,850 |
RGD:6480464 |
CTD |
| G |
Atf5 |
activating transcription factor 5 |
|
affects response to substance |
ISO |
1 |
95,284,505 |
95,286,786 |
RGD:6480464 |
CTD |
| G |
Atf7ip |
activating transcription factor 7 interacting protein |
|
affects expression |
ISO |
4 |
173,566,920 |
173,586,494 |
RGD:6480464 |
CTD |
| G |
Atg10 |
autophagy related 10 |
|
affects expression |
ISO |
2 |
21,076,289 |
21,374,627 |
RGD:6480464 |
CTD |
| G |
Atic |
5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase |
|
affects response to substance |
ISO |
9 |
70,676,744 |
70,696,865 |
RGD:6480464 |
CTD |
| G |
Atl2 |
atlastin GTPase 2 |
|
affects expression |
ISO |
6 |
2,728,722 |
2,771,082 |
RGD:6480464 |
CTD |
| G |
Atp1a1 |
ATPase, Na+/K+ transporting, alpha 1 polypeptide |
|
affects expression |
ISO |
2 |
196,657,749 |
196,687,242 |
RGD:6480464 |
CTD |
| G |
Atp1b2 |
ATPase, Na+/K+ transporting, beta 2 polypeptide |
|
affects expression |
ISO |
10 |
56,418,323 |
56,424,465 |
RGD:6480464 |
CTD |
| G |
Atp1b4 |
ATPase, (Na+)/K+ transporting, beta 4 polypeptide |
|
affects expression |
ISO |
X |
7,025,531 |
7,046,207 |
RGD:6480464 |
CTD |
| G |
Atp5d |
ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit |
|
affects response to substance |
ISO |
7 |
11,072,820 |
11,075,906 |
RGD:6480464 |
CTD |
| G |
Atp6v0d2 |
ATPase, H+ transporting, lysosomal V0 subunit D2 |
|
affects expression |
ISO |
5 |
34,476,045 |
34,524,995 |
RGD:6480464 |
CTD |
| G |
Avp |
arginine vasopressin |
|
increases secretion |
ISO |
3 |
118,205,007 |
118,206,985 |
RGD:6480464 |
CTD |
| G |
Avpr1a |
arginine vasopressin receptor 1A |
|
affects expression |
ISO |
7 |
62,225,537 |
62,229,461 |
RGD:6480464 |
CTD |
| G |
B3gnt3 |
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3 |
|
affects response to substance |
ISO |
16 |
18,892,320 |
18,901,908 |
RGD:6480464 |
CTD |
| G |
B4galt1 |
UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1 |
|
affects expression |
ISO |
5 |
58,196,388 |
58,243,231 |
RGD:6480464 |
CTD |
| G |
Bag3 |
Bcl2-associated athanogene 3 |
|
affects expression |
ISO |
1 |
187,781,147 |
187,804,835 |
RGD:6480464 |
CTD |
| G |
Bag6 |
BCL2-associated athanogene 6 |
|
affects response to substance |
ISO |
20 |
3,739,593 |
3,752,311 |
RGD:6480464 |
CTD |
| G |
Bbc3 |
Bcl-2 binding component 3 |
|
affects expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
decreases expression |
ISO |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcs1l |
BC1 (ubiquinol-cytochrome c reductase) synthesis-like |
|
affects expression |
ISO |
9 |
73,939,024 |
73,943,055 |
RGD:6480464 |
CTD |
| G |
Bmp2k |
BMP-2 inducible kinase |
|
affects expression |
ISO |
14 |
13,937,544 |
14,001,748 |
RGD:6480464 |
CTD |
| G |
Bmp4 |
bone morphogenetic protein 4 |
|
affects expression |
ISO |
15 |
22,283,171 |
22,286,757 |
RGD:6480464 |
CTD |
| G |
Bmper |
BMP-binding endothelial regulator |
|
affects expression |
ISO |
8 |
22,975,570 |
23,096,066 |
RGD:6480464 |
CTD |
| G |
Bnip3 |
BCL2/adenovirus E1B interacting protein 3 |
|
affects expression |
ISO |
1 |
198,683,009 |
198,700,075 |
RGD:6480464 |
CTD |
| G |
Bnip3 |
BCL2/adenovirus E1B interacting protein 3 |
|
affects response to substance |
ISO |
1 |
198,683,009 |
198,700,075 |
RGD:6480464 |
CTD |
| G |
Brca1 |
breast cancer 1, early onset |
|
multiple interactions |
ISO |
10 |
90,513,630 |
90,572,676 |
RGD:6480464 |
CTD |
| G |
Brd2 |
bromodomain containing 2 |
|
affects expression |
ISO |
20 |
4,864,606 |
4,871,813 |
RGD:6480464 |
CTD |
| G |
Bst2 |
bone marrow stromal cell antigen 2 |
|
affects response to substance |
ISO |
16 |
18,698,545 |
18,701,768 |
RGD:6480464 |
CTD |
| G |
Btbd3 |
BTB (POZ) domain containing 3 |
|
affects response to substance |
ISO |
3 |
126,403,030 |
126,409,372 |
RGD:6480464 |
CTD |
| G |
Bub3 |
budding uninhibited by benzimidazoles 3 homolog (S. cerevisiae) |
|
affects expression |
ISO |
1 |
191,128,891 |
191,139,401 |
RGD:6480464 |
CTD |
| G |
C1qb |
complement component 1, q subcomponent, B chain |
|
affects expression |
ISO |
5 |
155,647,524 |
155,653,074 |
RGD:6480464 |
CTD |
| G |
C3 |
complement component 3 |
|
affects expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
C8b |
complement component 8, beta polypeptide |
|
affects expression |
ISO |
5 |
125,728,606 |
125,766,093 |
RGD:6480464 |
CTD |
| G |
C9 |
complement component 9 |
|
affects expression |
ISO |
2 |
55,743,084 |
55,791,148 |
RGD:6480464 |
CTD |
| G |
Cabyr |
calcium binding tyrosine-(Y)-phosphorylation regulated |
|
affects expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Caln1 |
calneuron 1 |
|
affects expression |
ISO |
12 |
26,860,409 |
27,287,503 |
RGD:6480464 |
CTD |
| G |
Calr |
calreticulin |
|
affects response to substance |
ISO |
19 |
24,964,775 |
24,969,670 |
RGD:6480464 |
CTD |
| G |
Camk2g |
calcium/calmodulin-dependent protein kinase II gamma |
|
affects expression |
ISO |
15 |
3,729,433 |
3,786,060 |
RGD:6480464 |
CTD |
| G |
Camkk2 |
calcium/calmodulin-dependent protein kinase kinase 2, beta |
|
affects expression |
ISO |
12 |
34,907,317 |
34,938,479 |
RGD:6480464 |
CTD |
| G |
Cap2 |
CAP, adenylate cyclase-associated protein, 2 (yeast) |
|
affects expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Carhsp1 |
calcium regulated heat stable protein 1 |
|
affects expression |
ISO |
10 |
6,986,583 |
7,000,181 |
RGD:6480464 |
CTD |
| G |
Casp14 |
caspase 14 |
|
affects expression |
ISO |
7 |
12,487,166 |
12,489,998 |
RGD:6480464 |
CTD |
| G |
Casp8 |
caspase 8 |
|
increases expression |
ISO |
9 |
57,389,353 |
57,437,803 |
RGD:6480464 |
CTD |
| G |
Casp8 |
caspase 8 |
|
multiple interactions |
ISO |
9 |
57,389,353 |
57,437,803 |
RGD:6480464 |
CTD |
| G |
Ccl6 |
chemokine (C-C motif) ligand 6 |
|
affects expression |
ISO |
10 |
71,660,623 |
71,665,255 |
RGD:6480464 |
CTD |
| G |
Ccne1 |
cyclin E1 |
|
affects expression |
ISO |
1 |
90,568,189 |
90,577,426 |
RGD:6480464 |
CTD |
| G |
Ccne1 |
cyclin E1 |
|
increases expression |
EXP |
1 |
90,568,189 |
90,577,426 |
RGD:6480464 |
CTD |
| G |
Ccng1 |
cyclin G1 |
|
affects expression |
ISO |
10 |
25,776,380 |
25,782,754 |
RGD:6480464 |
CTD |
| G |
Ccrl2 |
chemokine (C-C motif) receptor-like 2 |
|
affects expression |
ISO |
8 |
115,451,786 |
115,454,088 |
RGD:6480464 |
CTD |
| G |
Ccrn4l |
CCR4 carbon catabolite repression 4-like (S. cerevisiae) |
|
affects expression |
ISO |
2 |
140,120,310 |
140,140,518 |
RGD:6480464 |
CTD |
| G |
Cd151 |
CD151 molecule (Raph blood group) |
|
affects response to substance |
ISO |
1 |
201,653,960 |
201,657,967 |
RGD:6480464 |
CTD |
| G |
Cd302 |
CD302 molecule |
|
affects response to substance |
ISO |
3 |
41,958,036 |
41,991,705 |
RGD:6480464 |
CTD |
| G |
Cd37 |
CD37 molecule |
|
affects expression |
ISO |
1 |
95,709,961 |
95,715,116 |
RGD:6480464 |
CTD |
| G |
Cd4 |
Cd4 molecule |
|
decreases expression |
ISO |
4 |
160,988,512 |
161,014,038 |
RGD:6480464 |
CTD |
| G |
Cd68 |
Cd68 molecule |
|
decreases expression |
ISO |
10 |
56,481,701 |
56,483,580 |
RGD:6480464 |
CTD |
| G |
Cd79a |
Cd79a molecule, immunoglobulin-associated alpha |
|
affects expression |
ISO |
1 |
80,189,446 |
80,205,354 |
RGD:6480464 |
CTD |
| G |
Cd8a |
CD8a molecule |
|
decreases expression |
ISO |
4 |
104,589,922 |
104,594,159 |
RGD:6480464 |
CTD |
| G |
Cd97 |
CD97 molecule |
|
affects expression |
ISO |
19 |
26,089,268 |
26,108,997 |
RGD:6480464 |
CTD |
| G |
Cdc25b |
cell division cycle 25B |
|
decreases expression |
EXP |
3 |
118,893,716 |
118,903,516 |
RGD:6480464 |
CTD |
| G |
Cdc34 |
cell division cycle 34 |
|
affects response to substance |
ISO |
7 |
11,534,543 |
11,539,941 |
RGD:6480464 |
CTD |
| G |
Cdh8 |
cadherin 8 |
|
affects expression |
ISO |
19 |
5,685,862 |
6,014,208 |
RGD:6480464 |
CTD |
| G |
Cdk2ap2 |
cyclin-dependent kinase 2 associated protein 2 |
|
affects response to substance |
ISO |
1 |
206,681,430 |
206,683,098 |
RGD:6480464 |
CTD |
| G |
Cdkal1 |
CDK5 regulatory subunit associated protein 1-like 1 |
|
affects expression |
ISO |
17 |
41,208,037 |
41,259,863 |
RGD:6480464 |
CTD |
| G |
Cdkl2 |
cyclin-dependent kinase-like 2 (CDC2-related kinase) |
|
affects expression |
ISO |
14 |
17,598,862 |
17,621,559 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
|
multiple interactions |
ISO |
20 |
7,376,325 |
7,386,778 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
|
increases expression |
ISO |
20 |
7,376,325 |
7,386,778 |
RGD:6480464 |
CTD |
| G |
Cdkn1b |
cyclin-dependent kinase inhibitor 1B |
|
affects response to substance |
ISO |
4 |
171,841,705 |
171,846,506 |
RGD:6480464 |
CTD |
| G |
Cdkn3 |
cyclin-dependent kinase inhibitor 3 |
|
decreases expression |
EXP |
15 |
22,617,409 |
22,624,922 |
RGD:6480464 |
CTD |
| G |
Celf3 |
CUGBP, Elav-like family member 3 |
|
affects expression |
ISO |
2 |
189,451,415 |
189,465,513 |
RGD:6480464 |
CTD |
| G |
Celsr1 |
cadherin, EGF LAG seven-pass G-type receptor 1 |
|
affects expression |
ISO |
7 |
123,900,366 |
124,036,122 |
RGD:6480464 |
CTD |
| G |
Cep41 |
centrosomal protein 41 |
|
affects expression |
ISO |
4 |
57,564,301 |
57,579,461 |
RGD:6480464 |
CTD |
| G |
Cep57 |
centrosomal protein 57 |
|
affects response to substance |
ISO |
8 |
10,608,688 |
10,627,914 |
RGD:6480464 |
CTD |
| G |
Cers5 |
ceramide synthase 5 |
|
affects expression |
ISO |
7 |
138,475,151 |
138,513,647 |
RGD:6480464 |
CTD |
| G |
Ces1d |
carboxylesterase 1D |
|
decreases expression |
EXP |
19 |
14,928,539 |
14,967,082 |
RGD:6480464 |
CTD |
| G |
Cfhr1 |
complement factor H-related 1 |
|
affects expression |
ISO |
13 |
53,135,397 |
53,150,381 |
RGD:6480464 |
CTD |
| G |
Cfhr1 |
complement factor H-related 1 |
|
affects expression |
ISO |
13 |
53,135,397 |
53,150,381 |
RGD:6480464 |
CTD |
| G |
Cga |
glycoprotein hormones, alpha polypeptide |
|
affects response to substance |
ISO |
5 |
51,538,259 |
51,550,324 |
RGD:6480464 |
CTD |
| G |
Cgref1 |
cell growth regulator with EF hand domain 1 |
|
increases expression |
EXP |
6 |
25,414,812 |
25,426,818 |
RGD:6480464 |
CTD |
| G |
Chchd2 |
coiled-coil-helix-coiled-coil-helix domain containing 2 |
|
affects expression |
ISO |
9 |
27,858,760 |
28,053,369 |
RGD:6480464 |
CTD |
| G |
Chka |
choline kinase alpha |
|
affects expression |
ISO |
1 |
206,368,963 |
206,418,526 |
RGD:6480464 |
CTD |
| G |
Chordc1 |
cysteine and histidine-rich domain (CHORD)-containing 1 |
|
affects expression |
ISO |
8 |
15,732,905 |
15,759,297 |
RGD:6480464 |
CTD |
| G |
Chrdl2 |
chordin-like 2 |
|
affects expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Chrna5 |
cholinergic receptor, nicotinic, alpha 5 (neuronal) |
|
affects expression |
ISO |
8 |
58,538,002 |
58,566,388 |
RGD:6480464 |
CTD |
| G |
Chst7 |
carbohydrate (N-acetylglucosamine 6-O) sulfotransferase 7 |
|
affects expression |
ISO |
X |
13,817,186 |
13,853,694 |
RGD:6480464 |
CTD |
| G |
Cirh1a |
cirrhosis, autosomal recessive 1A (cirhin) |
|
affects expression |
ISO |
19 |
36,742,206 |
36,770,285 |
RGD:6480464 |
CTD |
| G |
Ciz1 |
CDKN1A interacting zinc finger protein 1 |
|
affects response to substance |
ISO |
3 |
11,489,384 |
11,506,431 |
RGD:6480464 |
CTD |
| G |
Ckap4 |
cytoskeleton-associated protein 4 |
|
affects response to substance |
ISO |
7 |
21,360,351 |
21,368,448 |
RGD:6480464 |
CTD |
| G |
Ckmt1b |
creatine kinase, mitochondrial 1B |
|
affects response to substance |
ISO |
3 |
108,158,887 |
108,163,888 |
RGD:6480464 |
CTD |
| G |
Cldn1 |
claudin 1 |
|
affects expression |
ISO |
11 |
76,473,654 |
76,488,809 |
RGD:6480464 |
CTD |
| G |
Cldn7 |
claudin 7 |
|
affects expression |
ISO |
10 |
56,810,947 |
56,813,134 |
RGD:6480464 |
CTD |
| G |
Clip2 |
CAP-GLY domain containing linker protein 2 |
|
affects expression |
ISO |
12 |
23,228,309 |
23,292,105 |
RGD:6480464 |
CTD |
| G |
Cln3 |
ceroid-lipofuscinosis, neuronal 3 |
|
affects response to substance |
ISO |
1 |
185,713,096 |
185,724,375 |
RGD:6480464 |
CTD |
| G |
Cln8 |
ceroid-lipofuscinosis, neuronal 8 (epilepsy, progressive with mental retardation) |
|
affects expression |
ISO |
16 |
79,569,745 |
79,579,636 |
RGD:6480464 |
CTD |
| G |
Clptm1 |
cleft lip and palate associated transmembrane protein 1 |
|
affects response to substance |
ISO |
1 |
78,938,917 |
78,970,676 |
RGD:6480464 |
CTD |
| G |
Clpx |
ClpX caseinolytic peptidase X homolog (E. coli) |
|
affects expression |
ISO |
8 |
69,530,991 |
69,572,018 |
RGD:6480464 |
CTD |
| G |
Clstn1 |
calsyntenin 1 |
|
affects response to substance |
ISO |
5 |
166,671,098 |
166,734,907 |
RGD:6480464 |
CTD |
| G |
Cma1 |
chymase 1, mast cell |
|
affects expression |
ISO |
15 |
34,083,202 |
34,084,387 |
RGD:6480464 |
CTD |
| G |
Cndp1 |
carnosine dipeptidase 1 (metallopeptidase M20 family) |
|
affects expression |
ISO |
18 |
81,160,681 |
81,183,558 |
RGD:6480464 |
CTD |
| G |
Cnnm4 |
cyclin M4 |
|
affects expression |
ISO |
9 |
35,410,644 |
35,448,730 |
RGD:6480464 |
CTD |
| G |
Cnot3 |
CCR4-NOT transcription complex, subunit 3 |
|
affects response to substance |
ISO |
1 |
63,868,853 |
63,885,095 |
RGD:6480464 |
CTD |
| G |
Cnot7 |
CCR4-NOT transcription complex, subunit 7 |
|
affects expression |
ISO |
16 |
55,118,260 |
55,137,733 |
RGD:6480464 |
CTD |
| G |
Cnr1 |
cannabinoid receptor 1 (brain) |
|
affects expression |
ISO |
5 |
50,427,173 |
50,445,471 |
RGD:6480464 |
CTD |
| G |
Cntn6 |
contactin 6 |
|
affects expression |
ISO |
4 |
140,078,007 |
140,450,348 |
RGD:6480464 |
CTD |
| G |
Cog3 |
component of oligomeric golgi complex 3 |
|
affects expression |
ISO |
15 |
56,600,798 |
56,648,037 |
RGD:6480464 |
CTD |
| G |
Cog8 |
component of oligomeric golgi complex 8 |
|
affects expression |
ISO |
19 |
36,904,222 |
36,914,972 |
RGD:6480464 |
CTD |
| G |
Col15a1 |
collagen, type XV, alpha 1 |
|
affects response to substance |
ISO |
5 |
63,825,907 |
63,930,633 |
RGD:6480464 |
CTD |
| G |
Col4a4 |
collagen, type IV, alpha 4 |
|
increases expression |
ISO |
9 |
81,866,835 |
81,910,088 |
RGD:6480464 |
CTD |
| G |
Col5a3 |
collagen, type V, alpha 3 |
|
decreases expression |
EXP |
8 |
19,789,061 |
19,834,241 |
RGD:6480464 |
CTD |
| G |
Col6a1 |
collagen, type VI, alpha 1 |
|
affects expression |
ISO |
20 |
12,320,102 |
12,338,500 |
RGD:6480464 |
CTD |
| G |
Col8a1 |
collagen, type VIII, alpha 1 |
|
affects expression |
ISO |
11 |
43,604,994 |
43,733,870 |
RGD:6480464 |
CTD |
| G |
Comt |
catechol-O-methyltransferase |
|
increases expression |
EXP |
11 |
84,561,591 |
84,581,713 |
RGD:6480464 |
CTD |
| G |
Copg1 |
coatomer protein complex, subunit gamma 1 |
|
affects expression |
ISO |
4 |
122,109,613 |
122,134,049 |
RGD:6480464 |
CTD |
| G |
Cpeb2 |
cytoplasmic polyadenylation element binding protein 2 |
|
affects expression |
ISO |
14 |
72,955,778 |
73,007,518 |
RGD:6480464 |
CTD |
| G |
Cpn1 |
carboxypeptidase N, polypeptide 1 |
|
affects expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Cps1 |
carbamoyl-phosphate synthetase 1 |
|
affects response to substance |
ISO |
9 |
65,907,211 |
66,017,942 |
RGD:6480464 |
CTD |
| G |
Cpsf1 |
cleavage and polyadenylation specific factor 1, 160kDa |
|
affects response to substance |
ISO |
7 |
114,647,975 |
114,658,568 |
RGD:6480464 |
CTD |
| G |
Cpt1b |
carnitine palmitoyltransferase 1b, muscle |
|
decreases expression |
ISO |
7 |
127,737,129 |
127,746,179 |
RGD:6480464 |
CTD |
| G |
Crcp |
CGRP receptor component |
|
affects expression |
ISO |
12 |
27,666,950 |
27,702,741 |
RGD:6480464 |
CTD |
| G |
Creb3 |
cAMP responsive element binding protein 3 |
|
affects response to substance |
ISO |
5 |
60,040,874 |
60,045,512 |
RGD:6480464 |
CTD |
| G |
Cryba1 |
crystallin, beta A1 |
|
affects expression |
ISO |
10 |
63,758,929 |
63,765,451 |
RGD:6480464 |
CTD |
| G |
Csf2rb |
colony stimulating factor 2 receptor, beta, low-affinity (granulocyte-macrophage) |
|
affects expression |
ISO |
7 |
116,227,239 |
116,271,993 |
RGD:6480464 |
CTD |
| G |
Csrp3 |
cysteine and glycine-rich protein 3 (cardiac LIM protein) |
|
affects expression |
ISO |
1 |
98,601,681 |
98,611,747 |
RGD:6480464 |
CTD |
| G |
Cst6 |
cystatin E/M |
|
affects response to substance |
ISO |
1 |
207,991,313 |
207,993,021 |
RGD:6480464 |
CTD |
| G |
Csta |
cystatin A (stefin A) |
|
affects response to substance |
ISO |
11 |
66,456,248 |
66,467,253 |
RGD:6480464 |
CTD |
| G |
Cstf2t |
cleavage stimulation factor, 3' pre-RNA, subunit 2, 64kDa, tau variant |
|
affects expression |
ISO |
1 |
235,060,489 |
235,064,055 |
RGD:6480464 |
CTD |
| G |
Cth |
cystathionase (cystathionine gamma-lyase) |
|
affects response to substance |
ISO |
2 |
256,056,562 |
256,082,248 |
RGD:6480464 |
CTD |
| G |
Ctsl1 |
cathepsin L1 |
|
increases expression |
EXP |
17 |
6,288,013 |
6,294,174 |
RGD:6480464 |
CTD |
| G |
Ctss |
cathepsin S |
|
affects expression |
ISO |
2 |
190,425,290 |
190,466,877 |
RGD:6480464 |
CTD |
| G |
Cxcl10 |
chemokine (C-X-C motif) ligand 10 |
|
affects expression |
ISO |
14 |
17,265,986 |
17,268,183 |
RGD:6480464 |
CTD |
| G |
Cxcl10 |
chemokine (C-X-C motif) ligand 10 |
|
decreases expression |
EXP |
14 |
17,265,986 |
17,268,183 |
RGD:6480464 |
CTD |
| G |
Cxcl14 |
chemokine (C-X-C motif) ligand 14 |
|
affects expression |
ISO |
17 |
14,286,747 |
14,295,502 |
RGD:6480464 |
CTD |
| G |
Cxcr6 |
chemokine (C-X-C motif) receptor 6 |
|
affects expression |
ISO |
8 |
128,569,564 |
128,570,619 |
RGD:6480464 |
CTD |
| G |
Cyld |
cylindromatosis (turban tumor syndrome) |
|
affects expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Cyp17a1 |
cytochrome P450, family 17, subfamily a, polypeptide 1 |
|
affects expression |
ISO |
1 |
251,965,458 |
251,971,449 |
RGD:6480464 |
CTD |
| G |
Cyp19a1 |
cytochrome P450, family 19, subfamily a, polypeptide 1 |
|
affects expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
|
multiple interactions |
ISO |
8 |
61,439,062 |
61,447,861 |
RGD:6480464 |
CTD |
| G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
|
decreases expression |
EXP |
8 |
61,439,062 |
61,447,861 |
RGD:6480464 |
CTD |
| G |
Cyp2a1 |
cytochrome P450, family 2, subfamily a, polypeptide 1 |
|
affects expression |
ISO |
1 |
82,006,828 |
82,020,282 |
RGD:6480464 |
CTD |
| G |
Cyp2a3 |
cytochrome P450, family 2, subfamily a, polypeptide 3 |
|
affects expression |
ISO |
1 |
81,944,896 |
81,953,007 |
RGD:6480464 |
CTD |
| G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
|
decreases expression |
ISO |
12 |
9,517,016 |
9,541,000 |
RGD:6480464 |
CTD |
| G |
Cyp3a23/3a1 |
cytochrome P450, family 3, subfamily a, polypeptide 23/polypeptide 1 |
|
decreases expression |
EXP |
12 |
9,567,120 |
9,595,974 |
RGD:6480464 |
CTD |
| G |
Cyp4a1 |
cytochrome P450, family 4, subfamily a, polypeptide 1 |
|
decreases expression |
EXP |
5 |
135,901,653 |
135,915,754 |
RGD:6480464 |
CTD |
| G |
Cyp7a1 |
cytochrome P450, family 7, subfamily a, polypeptide 1 |
|
decreases expression |
EXP |
5 |
19,707,159 |
19,716,856 |
RGD:6480464 |
CTD |
| G |
Dapk3 |
death-associated protein kinase 3 |
|
affects response to substance |
ISO |
7 |
10,007,997 |
10,016,365 |
RGD:6480464 |
CTD |
| G |
Dbi |
diazepam binding inhibitor (GABA receptor modulator, acyl-CoA binding protein) |
|
affects expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Dbn1 |
drebrin 1 |
|
affects response to substance |
ISO |
17 |
15,194,687 |
15,208,660 |
RGD:6480464 |
CTD |
| G |
Dcp2 |
DCP2 decapping enzyme homolog (S. cerevisiae) |
|
affects response to substance |
ISO |
18 |
38,050,088 |
38,086,422 |
RGD:6480464 |
CTD |
| G |
Ddit3 |
DNA-damage inducible transcript 3 |
|
affects expression |
ISO |
7 |
67,247,749 |
67,252,571 |
RGD:6480464 |
CTD |
| G |
Ddx21 |
DEAD (Asp-Glu-Ala-Asp) box helicase 21 |
|
affects expression |
ISO |
20 |
29,838,671 |
29,860,514 |
RGD:6480464 |
CTD |
| G |
Ddx27 |
DEAD (Asp-Glu-Ala-Asp) box polypeptide 27 |
|
affects expression |
ISO |
3 |
158,165,670 |
158,185,490 |
RGD:6480464 |
CTD |
| G |
Ddx5 |
DEAD (Asp-Glu-Ala-Asp) box helicase 5 |
|
affects expression |
ISO |
10 |
96,131,888 |
96,139,423 |
RGD:6480464 |
CTD |
| G |
Des |
desmin |
|
increases expression |
ISO |
9 |
74,637,783 |
74,645,499 |
RGD:6480464 |
CTD |
| G |
Dgcr6 |
DiGeorge syndrome critical region gene 6 |
|
affects response to substance |
ISO |
11 |
84,922,649 |
84,927,694 |
RGD:6480464 |
CTD |
| G |
Dhfr |
dihydrofolate reductase |
|
decreases response to substance |
ISO |
2 |
22,607,093 |
22,828,487 |
RGD:6480464 |
CTD |
| G |
Dhrs2 |
dehydrogenase/reductase (SDR family) member 2 |
|
affects response to substance |
ISO |
15 |
33,286,599 |
33,337,467 |
RGD:6480464 |
CTD |
| G |
Dhx15 |
DEAH (Asp-Glu-Ala-His) box polypeptide 15 |
|
affects response to substance |
ISO |
14 |
63,563,251 |
63,601,200 |
RGD:6480464 |
CTD |
| G |
Dhx33 |
DEAH (Asp-Glu-Ala-His) box polypeptide 33 |
|
affects expression |
ISO |
10 |
57,889,929 |
57,906,392 |
RGD:6480464 |
CTD |
| G |
Diaph3 |
diaphanous homolog 3 (Drosophila) |
|
affects expression |
ISO |
15 |
68,905,784 |
69,267,707 |
RGD:6480464 |
CTD |
| G |
Dkk1 |
dickkopf 1 homolog (Xenopus laevis) |
|
decreases expression |
ISO |
1 |
234,392,743 |
234,396,426 |
RGD:6480464 |
CTD |
| G |
Dkk1 |
dickkopf 1 homolog (Xenopus laevis) |
|
decreases expression |
ISO |
1 |
234,392,743 |
234,396,426 |
RGD:6480464 |
CTD |
| G |
Dll1 |
delta-like 1 (Drosophila) |
|
affects expression |
ISO |
1 |
54,240,395 |
54,248,183 |
RGD:6480464 |
CTD |
| G |
Dll4 |
delta-like 4 (Drosophila) |
|
affects expression |
ISO |
3 |
105,844,671 |
105,854,738 |
RGD:6480464 |
CTD |
| G |
Dnaja1 |
DnaJ (Hsp40) homolog, subfamily A, member 1 |
|
affects expression |
ISO |
5 |
58,100,794 |
58,111,705 |
RGD:6480464 |
CTD |
| G |
Dnajb1 |
DnaJ (Hsp40) homolog, subfamily B, member 1 |
|
affects expression |
ISO |
19 |
26,213,739 |
26,217,480 |
RGD:6480464 |
CTD |
| G |
Dnajb9 |
DnaJ (Hsp40) homolog, subfamily B, member 9 |
|
affects expression |
ISO |
6 |
63,583,033 |
63,587,247 |
RGD:6480464 |
CTD |
| G |
Dnajc5 |
DnaJ (Hsp40) homolog, subfamily C, member 5 |
|
affects expression |
ISO |
3 |
170,655,557 |
170,685,855 |
RGD:6480464 |
CTD |
| G |
Dnajc6 |
DnaJ (Hsp40) homolog, subfamily C, member 6 |
|
affects expression |
ISO |
5 |
122,155,150 |
122,309,090 |
RGD:6480464 |
CTD |
| G |
Dnase2b |
deoxyribonuclease II beta |
|
affects expression |
ISO |
2 |
244,779,607 |
244,794,980 |
RGD:6480464 |
CTD |
| G |
Dnmbp |
dynamin binding protein |
|
affects expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Doc2a |
double C2-like domains, alpha |
|
affects expression |
ISO |
1 |
186,027,821 |
186,031,461 |
RGD:6480464 |
CTD |
| G |
Dok4 |
docking protein 4 |
|
affects expression |
ISO |
19 |
10,585,647 |
10,596,322 |
RGD:6480464 |
CTD |
| G |
Dppa4 |
developmental pluripotency associated 4 |
|
affects expression |
ISO |
11 |
53,842,178 |
53,850,375 |
RGD:6480464 |
CTD |
| G |
Drap1 |
Dr1 associated protein 1 (negative cofactor 2 alpha) |
|
affects response to substance |
ISO |
1 |
208,067,906 |
208,070,556 |
RGD:6480464 |
CTD |
| G |
Dtx4 |
deltex homolog 4 (Drosophila) |
|
affects expression |
ISO |
1 |
215,396,194 |
215,416,879 |
RGD:6480464 |
CTD |
| G |
Dusp10 |
dual specificity phosphatase 10 |
|
affects expression |
ISO |
13 |
100,022,421 |
100,059,539 |
RGD:6480464 |
CTD |
| G |
Dusp3 |
dual specificity phosphatase 3 |
|
affects expression |
ISO |
10 |
91,031,206 |
91,044,858 |
RGD:6480464 |
CTD |
| G |
Dusp4 |
dual specificity phosphatase 4 |
|
affects response to substance |
ISO |
16 |
61,109,626 |
61,119,981 |
RGD:6480464 |
CTD |
| G |
Dyt1 |
dystonia 1 |
|
affects expression |
ISO |
3 |
10,026,129 |
10,033,125 |
RGD:6480464 |
CTD |
| G |
Ednrb |
endothelin receptor type B |
|
affects expression |
ISO |
15 |
87,893,141 |
87,898,700 |
RGD:6480464 |
CTD |
| G |
Eed |
embryonic ectoderm development |
|
affects response to substance |
ISO |
1 |
146,563,961 |
146,591,042 |
RGD:6480464 |
CTD |
| G |
Efhd2 |
EF-hand domain family, member D2 |
|
affects expression |
ISO |
5 |
160,759,737 |
160,775,765 |
RGD:6480464 |
CTD |
| G |
Efnb1 |
ephrin B1 |
|
affects expression |
ISO |
X |
87,163,176 |
87,175,982 |
RGD:6480464 |
CTD |
| G |
Egfl6 |
EGF-like-domain, multiple 6 |
|
affects expression |
ISO |
X |
48,568,644 |
48,626,802 |
RGD:6480464 |
CTD |
| G |
Egr1 |
early growth response 1 |
|
affects expression |
ISO |
18 |
27,343,919 |
27,346,117 |
RGD:6480464 |
CTD |
| G |
Ehhadh |
enoyl-CoA, hydratase/3-hydroxyacyl CoA dehydrogenase |
|
decreases expression |
EXP |
11 |
81,474,161 |
81,507,645 |
RGD:6480464 |
CTD |
| G |
Eif2b5 |
eukaryotic translation initiation factor 2B, subunit 5 epsilon |
|
affects expression |
ISO |
11 |
82,634,006 |
82,643,992 |
RGD:6480464 |
CTD |
| G |
Eif4a1 |
eukaryotic translation initiation factor 4A1 |
|
affects expression |
ISO |
10 |
56,484,232 |
56,489,739 |
RGD:6480464 |
CTD |
| G |
Eif5a |
eukaryotic translation initiation factor 5A |
|
affects response to substance |
ISO |
10 |
56,760,289 |
56,764,689 |
RGD:6480464 |
CTD |
| G |
Elovl3 |
ELOVL fatty acid elongase 3 |
|
affects expression |
ISO |
1 |
251,351,908 |
251,355,736 |
RGD:6480464 |
CTD |
| G |
Elp4 |
elongator acetyltransferase complex subunit 4 |
|
affects expression |
ISO |
3 |
91,154,930 |
91,309,491 |
RGD:6480464 |
CTD |
| G |
Emr1 |
EGF-like module containing, mucin-like, hormone receptor-like 1 |
|
affects expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Enc1 |
ectodermal-neural cortex 1 |
|
increases expression |
EXP |
2 |
27,720,805 |
27,733,168 |
RGD:6480464 |
CTD |
| G |
Enpp1 |
ectonucleotide pyrophosphatase/phosphodiesterase 1 |
|
affects expression |
ISO |
1 |
21,223,678 |
21,287,411 |
RGD:6480464 |
CTD |
| G |
Entpd3 |
ectonucleoside triphosphate diphosphohydrolase 3 |
|
affects expression |
ISO |
8 |
125,542,934 |
125,573,945 |
RGD:6480464 |
CTD |
| G |
Entpd8 |
ectonucleoside triphosphate diphosphohydrolase 8 |
|
affects expression |
ISO |
3 |
5,229,747 |
5,258,064 |
RGD:6480464 |
CTD |
| G |
Epb41l3 |
erythrocyte membrane protein band 4.1-like 3 |
|
affects expression |
ISO |
9 |
108,303,607 |
108,426,942 |
RGD:6480464 |
CTD |
| G |
Epha2 |
Eph receptor A2 |
|
affects expression |
ISO |
5 |
160,185,143 |
160,214,727 |
RGD:6480464 |
CTD |
| G |
Eprs |
glutamyl-prolyl-tRNA synthetase |
|
affects response to substance |
ISO |
13 |
101,375,656 |
101,448,175 |
RGD:6480464 |
CTD |
| G |
Epx |
eosinophil peroxidase |
|
affects expression |
ISO |
10 |
76,160,005 |
76,171,089 |
RGD:6480464 |
CTD |
| G |
Erbb2 |
v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) |
|
affects response to substance |
ISO |
10 |
87,219,157 |
87,242,919 |
RGD:6480464 |
CTD |
| G |
Ern1 |
endoplasmic reticulum to nucleus signaling 1 |
|
affects expression |
ISO |
10 |
95,794,488 |
95,855,895 |
RGD:6480464 |
CTD |
| G |
Espn |
espin |
|
increases expression |
EXP |
5 |
169,349,723 |
169,382,076 |
RGD:6480464 |
CTD |
| G |
Esyt1 |
extended synaptotagmin-like protein 1 |
|
affects response to substance |
ISO |
7 |
1,790,700 |
1,808,060 |
RGD:6480464 |
CTD |
| G |
Ethe1 |
ethylmalonic encephalopathy 1 |
|
affects expression |
ISO |
1 |
79,875,629 |
79,890,681 |
RGD:6480464 |
CTD |
| G |
Evl |
Enah/Vasp-like |
|
affects response to substance |
ISO |
6 |
132,952,804 |
133,019,870 |
RGD:6480464 |
CTD |
| G |
Exoc7 |
exocyst complex component 7 |
|
affects response to substance |
ISO |
10 |
106,400,889 |
106,419,793 |
RGD:6480464 |
CTD |
| G |
Eya3 |
eyes absent homolog 3 (Drosophila) |
|
affects expression |
ISO |
5 |
152,427,552 |
152,507,813 |
RGD:6480464 |
CTD |
| G |
F11 |
coagulation factor XI |
|
affects expression |
ISO |
16 |
50,276,330 |
50,298,903 |
RGD:6480464 |
CTD |
| G |
F12 |
coagulation factor XII (Hageman factor) |
|
affects response to substance |
ISO |
17 |
15,251,611 |
15,259,583 |
RGD:6480464 |
CTD |
| G |
F3 |
coagulation factor III (thromboplastin, tissue factor) |
|
increases expression |
ISO |
2 |
218,371,050 |
218,382,645 |
RGD:6480464 |
CTD |
| G |
F3 |
coagulation factor III (thromboplastin, tissue factor) |
|
increases expression |
EXP |
2 |
218,371,050 |
218,382,645 |
RGD:6480464 |
CTD |
| G |
Fabp1 |
fatty acid binding protein 1, liver |
|
decreases expression |
EXP |
4 |
104,412,200 |
104,415,981 |
RGD:6480464 |
CTD |
| G |
Fads1 |
fatty acid desaturase 1 |
|
affects response to substance |
ISO |
1 |
212,670,792 |
212,685,718 |
RGD:6480464 |
CTD |
| G |
Fads2 |
fatty acid desaturase 2 |
|
affects response to substance |
ISO |
1 |
212,512,691 |
212,542,622 |
RGD:6480464 |
CTD |
| G |
Fam115e |
family with sequence similarity 115, member E |
|
affects expression |
ISO |
4 |
70,401,082 |
70,419,847 |
RGD:6480464 |
CTD |
| G |
Fam171a1 |
family with sequence similarity 171, member A1 |
|
affects response to substance |
ISO |
17 |
86,143,621 |
86,266,740 |
RGD:6480464 |
CTD |
| G |
Fas |
Fas (TNF receptor superfamily, member 6) |
|
decreases expression |
ISO |
1 |
238,259,443 |
238,274,745 |
RGD:6480464 |
CTD |
| G |
Fbln5 |
fibulin 5 |
|
decreases expression |
EXP |
6 |
126,018,541 |
126,098,234 |
RGD:6480464 |
CTD |
| G |
Fbxw4 |
F-box and WD repeat domain containing 4 |
|
affects expression |
ISO |
1 |
250,746,869 |
250,874,460 |
RGD:6480464 |
CTD |
| G |
Fem1a |
fem-1 homolog a (C. elegans) |
|
affects expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Fga |
fibrinogen alpha chain |
|
decreases expression |
EXP |
2 |
174,737,640 |
174,753,598 |
RGD:6480464 |
CTD |
| G |
Fgd4 |
FYVE, RhoGEF and PH domain containing 4 |
|
affects expression |
ISO |
11 |
86,700,118 |
86,767,928 |
RGD:6480464 |
CTD |
| G |
Fgf1 |
fibroblast growth factor 1 (acidic) |
|
affects expression |
ISO |
18 |
31,785,480 |
31,806,452 |
RGD:6480464 |
CTD |
| G |
Fgf16 |
fibroblast growth factor 16 |
|
affects expression |
ISO |
X |
93,870,484 |
93,880,067 |
RGD:6480464 |
CTD |
| G |
Fgf20 |
fibroblast growth factor 20 |
|
affects expression |
ISO |
16 |
55,386,987 |
55,393,744 |
RGD:6480464 |
CTD |
| G |
Fgf3 |
fibroblast growth factor 3 |
|
affects expression |
ISO |
1 |
205,269,480 |
205,273,404 |
RGD:6480464 |
CTD |
| G |
Fgfr1 |
Fibroblast growth factor receptor 1 |
|
affects response to substance |
ISO |
16 |
70,869,974 |
70,910,045 |
RGD:6480464 |
CTD |
| G |
Fh |
fumarate hydratase |
|
affects expression |
ISO |
13 |
91,329,837 |
91,355,722 |
RGD:6480464 |
CTD |
| G |
Fip1l1 |
FIP1 like 1 (S. cerevisiae) |
|
affects expression |
ISO |
14 |
35,993,131 |
36,050,974 |
RGD:6480464 |
CTD |
| G |
Fkbp5 |
FK506 binding protein 5 |
|
increases expression |
EXP |
20 |
6,637,478 |
6,686,768 |
RGD:6480464 |
CTD |
| G |
Flrt2 |
fibronectin leucine rich transmembrane protein 2 |
|
affects response to substance |
ISO |
6 |
119,569,366 |
119,658,949 |
RGD:6480464 |
CTD |
| G |
Fmo2 |
flavin containing monooxygenase 2 |
|
affects expression |
ISO |
13 |
78,546,315 |
78,592,870 |
RGD:6480464 |
CTD |
| G |
Fmo3 |
flavin containing monooxygenase 3 |
|
affects expression |
ISO |
13 |
78,659,513 |
78,678,524 |
RGD:6480464 |
CTD |
| G |
Fmo5 |
flavin containing monooxygenase 5 |
|
affects expression |
ISO |
2 |
192,463,087 |
192,489,803 |
RGD:6480464 |
CTD |
| G |
Fmod |
fibromodulin |
|
affects response to substance |
ISO |
13 |
46,987,714 |
46,998,331 |
RGD:6480464 |
CTD |
| G |
Fnbp1 |
formin binding protein 1 |
|
affects response to substance |
ISO |
3 |
10,091,465 |
10,162,829 |
RGD:6480464 |
CTD |
| G |
Foxe3 |
forkhead box E3 |
|
affects expression |
ISO |
5 |
135,285,688 |
135,286,548 |
RGD:6480464 |
CTD |
| G |
Foxn3 |
forkhead box N3 |
|
affects response to substance |
ISO |
6 |
123,385,156 |
123,762,322 |
RGD:6480464 |
CTD |
| G |
Foxo1 |
forkhead box O1 |
|
affects expression |
ISO |
2 |
141,127,345 |
141,203,446 |
RGD:6480464 |
CTD |
| G |
Fpgs |
folylpolyglutamate synthase |
|
increases metabolic processing |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Fpr-rs4 |
formyl peptide receptor, related sequence 4 |
|
affects expression |
ISO |
1 |
56,838,504 |
56,839,475 |
RGD:6480464 |
CTD |
| G |
Fst |
follistatin |
|
affects expression |
ISO |
2 |
46,542,246 |
46,550,678 |
RGD:6480464 |
CTD |
| G |
Fstl1 |
follistatin-like 1 |
|
affects response to substance |
ISO |
11 |
64,681,814 |
64,735,673 |
RGD:6480464 |
CTD |
| G |
Ftsj3 |
FtsJ homolog 3 (E. coli) |
|
affects expression |
ISO |
10 |
95,644,169 |
95,650,613 |
RGD:6480464 |
CTD |
| G |
Fut7 |
fucosyltransferase 7 (alpha (1,3) fucosyltransferase) |
|
affects expression |
ISO |
3 |
3,590,174 |
3,593,046 |
RGD:6480464 |
CTD |
| G |
Fzd4 |
frizzled family receptor 4 |
|
affects expression |
ISO |
1 |
145,953,743 |
145,957,666 |
RGD:6480464 |
CTD |
| G |
Gabrp |
gamma-aminobutyric acid (GABA-A) receptor, pi |
|
affects expression |
ISO |
10 |
18,454,555 |
18,474,564 |
RGD:6480464 |
CTD |
| G |
Gad1 |
glutamate decarboxylase 1 |
|
affects response to substance |
ISO |
3 |
52,789,370 |
52,830,038 |
RGD:6480464 |
CTD |
| G |
Gale |
UDP-galactose-4-epimerase |
|
affects expression |
ISO |
5 |
154,745,853 |
154,750,357 |
RGD:6480464 |
CTD |
| G |
Galnt4 |
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 4 (GalNAc-T4) |
|
affects expression |
ISO |
7 |
36,684,516 |
36,687,057 |
RGD:6480464 |
CTD |
| G |
Gamt |
guanidinoacetate N-methyltransferase |
|
affects response to substance |
ISO |
7 |
10,959,990 |
10,962,720 |
RGD:6480464 |
CTD |
| G |
Gata5 |
GATA binding protein 5 |
|
affects expression |
ISO |
3 |
169,385,321 |
169,393,508 |
RGD:6480464 |
CTD |
| G |
Gclc |
glutamate-cysteine ligase, catalytic subunit |
|
affects expression |
ISO |
8 |
82,724,429 |
82,762,848 |
RGD:6480464 |
CTD |
| G |
Gcsh |
glycine cleavage system protein H (aminomethyl carrier) |
|
affects response to substance |
ISO |
19 |
47,091,226 |
47,101,983 |
RGD:6480464 |
CTD |
| G |
Gdf10 |
growth differentiation factor 10 |
|
affects expression |
ISO |
16 |
9,558,781 |
9,570,656 |
RGD:6480464 |
CTD |
| G |
Gemin4 |
gem (nuclear organelle) associated protein 4 |
|
affects expression |
ISO |
10 |
63,564,269 |
63,571,193 |
RGD:6480464 |
CTD |
| G |
Gga3 |
golgi associated, gamma adaptin ear containing, ARF binding protein 3 |
|
affects expression |
ISO |
10 |
105,665,476 |
105,684,513 |
RGD:6480464 |
CTD |
| G |
Ggnbp2 |
gametogenetin binding protein 2 |
|
affects expression |
ISO |
10 |
73,114,838 |
73,146,171 |
RGD:6480464 |
CTD |
| G |
Gldc |
glycine dehydrogenase (decarboxylating) |
|
affects expression |
ISO |
1 |
233,846,690 |
233,925,736 |
RGD:6480464 |
CTD |
| G |
Gna11 |
guanine nucleotide binding protein, alpha 11 |
|
affects response to substance |
ISO |
7 |
9,636,748 |
9,662,492 |
RGD:6480464 |
CTD |
| G |
Gnai2 |
guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 2 |
|
affects expression |
ISO |
8 |
112,861,952 |
112,882,647 |
RGD:6480464 |
CTD |
| G |
Gnat1 |
guanine nucleotide binding protein (G protein), alpha transducing activity polypeptide 1 |
|
affects expression |
ISO |
8 |
112,925,418 |
112,930,154 |
RGD:6480464 |
CTD |
| G |
Gne |
glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase |
|
affects response to substance |
ISO |
5 |
60,506,171 |
60,536,403 |
RGD:6480464 |
CTD |
| G |
Gne |
glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase |
|
affects expression |
ISO |
5 |
60,506,171 |
60,536,403 |
RGD:6480464 |
CTD |
| G |
Gng11 |
guanine nucleotide binding protein (G protein), gamma 11 |
|
affects response to substance |
ISO |
4 |
28,847,907 |
28,853,347 |
RGD:6480464 |
CTD |
| G |
Gng3 |
guanine nucleotide binding protein (G protein), gamma 3 |
|
affects expression |
ISO |
1 |
211,507,640 |
211,509,406 |
RGD:6480464 |
CTD |
| G |
Gpbar1 |
G protein-coupled bile acid receptor 1 |
|
affects expression |
ISO |
9 |
73,605,141 |
73,606,130 |
RGD:6480464 |
CTD |
| G |
Gpr37l1 |
G protein-coupled receptor 37-like 1 |
|
affects expression |
ISO |
13 |
48,121,001 |
48,127,850 |
RGD:6480464 |
CTD |
| G |
Gpt2 |
glutamic pyruvate transaminase (alanine aminotransferase) 2 |
|
affects expression |
ISO |
19 |
22,884,586 |
22,915,553 |
RGD:6480464 |
CTD |
| G |
Gpx2 |
glutathione peroxidase 2 |
|
affects response to substance |
ISO |
6 |
99,372,418 |
99,376,230 |
RGD:6480464 |
CTD |
| G |
Gpx3 |
glutathione peroxidase 3 |
|
affects response to substance |
ISO |
10 |
40,311,094 |
40,319,382 |
RGD:6480464 |
CTD |
| G |
Grb10 |
growth factor receptor bound protein 10 |
|
affects expression |
ISO |
14 |
92,814,797 |
92,911,442 |
RGD:6480464 |
CTD |
| G |
Grem2 |
gremlin 2 |
|
affects expression |
ISO |
13 |
90,528,920 |
90,622,303 |
RGD:6480464 |
CTD |
| G |
Grik1 |
glutamate receptor, ionotropic, kainate 1 |
|
affects expression |
ISO |
11 |
27,703,874 |
28,106,450 |
RGD:6480464 |
CTD |
| G |
Grin3b |
glutamate receptor, ionotropic, N-methyl-D-aspartate 3B |
|
affects response to substance |
ISO |
7 |
11,243,973 |
11,250,311 |
RGD:6480464 |
CTD |
| G |
Grn |
granulin |
|
affects response to substance |
ISO |
10 |
91,536,135 |
91,542,239 |
RGD:6480464 |
CTD |
| G |
Grwd1 |
glutamate-rich WD repeat containing 1 |
|
affects expression |
ISO |
1 |
96,301,559 |
96,307,145 |
RGD:6480464 |
CTD |
| G |
Gsta2 |
glutathione S-transferase alpha 2 |
|
decreases expression |
EXP |
8 |
83,299,249 |
83,312,958 |
RGD:6480464 |
CTD |
| G |
Gstm1 |
glutathione S-transferase mu 1 |
|
affects expression |
ISO |
2 |
203,575,444 |
203,580,821 |
RGD:6480464 |
CTD |
| G |
Gstm1 |
glutathione S-transferase mu 1 |
|
affects response to substance |
ISO |
2 |
203,575,444 |
203,580,821 |
RGD:6480464 |
CTD |
| G |
Gtpbp4 |
GTP binding protein 4 |
|
affects expression |
ISO |
17 |
72,100,899 |
72,120,636 |
RGD:6480464 |
CTD |
| G |
Gucy1b2 |
guanylate cyclase 1, soluble, beta 2 |
|
decreases expression |
EXP |
15 |
41,620,373 |
41,668,802 |
RGD:6480464 |
CTD |
| G |
Gucy1b3 |
guanylate cyclase 1, soluble, beta 3 |
|
affects expression |
ISO |
2 |
173,683,153 |
173,735,298 |
RGD:6480464 |
CTD |
| G |
H1foo |
H1 histone family, member O, oocyte-specific |
|
affects expression |
ISO |
4 |
152,070,310 |
152,075,730 |
RGD:6480464 |
CTD |
| G |
H1fx |
H1 histone family, member X |
|
affects response to substance |
ISO |
4 |
122,179,764 |
122,180,823 |
RGD:6480464 |
CTD |
| G |
H2afx |
H2A histone family, member X |
|
affects response to substance |
ISO |
8 |
47,312,609 |
47,313,938 |
RGD:6480464 |
CTD |
| G |
Hacl1 |
2-hydroxyacyl-CoA lyase 1 |
|
decreases expression |
EXP |
16 |
7,073,038 |
7,108,830 |
RGD:6480464 |
CTD |
| G |
Hapln2 |
hyaluronan and proteoglycan link protein 2 |
|
affects expression |
ISO |
2 |
180,104,684 |
180,110,113 |
RGD:6480464 |
CTD |
| G |
Hba2 |
hemoglobin, alpha 2 |
|
affects expression |
ISO |
10 |
15,570,930 |
15,571,773 |
RGD:6480464 |
CTD |
| G |
Hbe1 |
hemoglobin, epsilon 1 |
|
affects expression |
ISO |
1 |
161,651,422 |
161,652,702 |
RGD:6480464 |
CTD |
| G |
Hccs |
holocytochrome c synthase |
|
affects expression |
ISO |
X |
45,617,395 |
45,626,790 |
RGD:6480464 |
CTD |
| G |
Hck |
hemopoietic cell kinase |
|
affects expression |
ISO |
3 |
143,447,697 |
143,490,281 |
RGD:6480464 |
CTD |
| G |
Hcrt |
hypocretin |
|
affects expression |
ISO |
10 |
89,699,633 |
89,700,847 |
RGD:6480464 |
CTD |
| G |
Hdac4 |
histone deacetylase 4 |
|
affects response to substance |
ISO |
9 |
91,147,435 |
91,389,810 |
RGD:6480464 |
CTD |
| G |
Hdgfrp3 |
hepatoma-derived growth factor, related protein 3 |
|
affects response to substance |
ISO |
1 |
138,098,818 |
138,130,696 |
RGD:6480464 |
CTD |
| G |
Hdhd1 |
haloacid dehalogenase-like hydrolase domain containing 1 |
|
affects response to substance |
ISO |
18 |
45,741,982 |
45,743,005 |
RGD:6480464 |
CTD |
| G |
Herpud1 |
homocysteine-inducible, endoplasmic reticulum stress-inducible, ubiquitin-like domain member 1 |
|
affects expression |
ISO |
19 |
11,036,567 |
11,046,914 |
RGD:6480464 |
CTD |
| G |
Hes1 |
hairy and enhancer of split 1 (Drosophila) |
|
affects expression |
ISO |
11 |
72,603,482 |
72,605,673 |
RGD:6480464 |
CTD |
| G |
Hgs |
hepatocyte growth factor-regulated tyrosine kinase substrate |
|
affects response to substance |
ISO |
10 |
109,861,289 |
109,869,587 |
RGD:6480464 |
CTD |
| G |
Hhex |
hematopoietically expressed homeobox |
|
affects expression |
ISO |
1 |
241,736,542 |
241,742,129 |
RGD:6480464 |
CTD |
| G |
Hlxb9 |
homeobox gene HB9 |
|
affects expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Hmgcs2 |
3-hydroxy-3-methylglutaryl-CoA synthase 2 (mitochondrial) |
|
decreases expression |
EXP |
2 |
193,128,736 |
193,143,106 |
RGD:6480464 |
CTD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
increases expression |
EXP |
19 |
13,963,139 |
13,969,960 |
RGD:6480464 |
CTD |
| G |
Hnrpd |
heterogeneous nuclear ribonucleoprotein D |
|
affects expression |
ISO |
14 |
10,917,674 |
10,935,989 |
RGD:6480464 |
CTD |
| G |
Hnrph1 |
heterogeneous nuclear ribonucleoprotein H1 |
|
affects response to substance |
ISO |
10 |
35,922,840 |
35,930,132 |
RGD:6480464 |
CTD |
| G |
Hoxc10 |
homeo box C10 |
|
affects expression |
ISO |
7 |
141,717,910 |
141,734,613 |
RGD:6480464 |
CTD |
| G |
Hpse |
heparanase |
|
affects expression |
ISO |
14 |
10,144,322 |
10,185,115 |
RGD:6480464 |
CTD |
| G |
Hsd3b1 |
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1 |
|
affects expression |
ISO |
2 |
193,337,342 |
193,346,799 |
RGD:6480464 |
CTD |
| G |
Hsf2 |
heat shock transcription factor 2 |
|
affects expression |
ISO |
20 |
36,520,685 |
36,538,506 |
RGD:6480464 |
CTD |
| G |
Hsp90b1 |
heat shock protein 90, beta, member 1 |
|
affects expression |
ISO |
7 |
23,332,986 |
23,347,525 |
RGD:6480464 |
CTD |
| G |
Hspa4 |
heat shock protein 4 |
|
affects expression |
ISO |
10 |
38,705,629 |
38,749,058 |
RGD:6480464 |
CTD |
| G |
Hspa8 |
heat shock 70kDa protein 8 |
|
affects expression |
ISO |
8 |
43,784,035 |
43,787,760 |
RGD:6480464 |
CTD |
| G |
Hspb1 |
heat shock protein 1 |
|
affects expression |
ISO |
12 |
21,911,223 |
21,912,784 |
RGD:6480464 |
CTD |
| G |
Hspb1 |
heat shock protein 1 |
|
increases expression |
ISO |
12 |
21,911,223 |
21,912,784 |
RGD:6480464 |
CTD |
| G |
Hspb1 |
heat shock protein 1 |
|
multiple interactions |
ISO |
12 |
21,911,223 |
21,912,784 |
RGD:6480464 |
CTD |
| G |
Hspd1 |
heat shock protein 1 (chaperonin) |
|
affects expression |
ISO |
9 |
53,884,193 |
53,895,043 |
RGD:6480464 |
CTD |
| G |
Htra1 |
HtrA serine peptidase 1 |
|
affects expression |
ISO |
1 |
190,257,899 |
190,308,325 |
RGD:6480464 |
CTD |
| G |
Icam1 |
intercellular adhesion molecule 1 |
|
decreases expression |
ISO |
8 |
20,040,177 |
20,051,939 |
RGD:6480464 |
CTD |
| G |
Id1 |
inhibitor of DNA binding 1 |
|
affects expression |
ISO |
3 |
143,086,162 |
143,087,289 |
RGD:6480464 |
CTD |
| G |
Idh3a |
isocitrate dehydrogenase 3 (NAD+) alpha |
|
affects expression |
ISO |
8 |
58,135,412 |
58,156,019 |
RGD:6480464 |
CTD |
| G |
Igfbp3 |
insulin-like growth factor binding protein 3 |
|
decreases expression |
EXP |
14 |
87,959,153 |
87,967,085 |
RGD:6480464 |
CTD |
| G |
Igfbp5 |
insulin-like growth factor binding protein 5 |
|
increases expression |
EXP |
9 |
72,003,637 |
72,016,263 |
RGD:6480464 |
CTD |
| G |
Igfbp7 |
insulin-like growth factor binding protein 7 |
|
affects response to substance |
ISO |
14 |
33,010,198 |
33,070,055 |
RGD:6480464 |
CTD |
| G |
Igsf3 |
immunoglobulin superfamily, member 3 |
|
affects expression |
ISO |
2 |
196,495,204 |
196,530,084 |
RGD:6480464 |
CTD |
| G |
Ihh |
Indian hedgehog |
|
affects expression |
ISO |
9 |
74,287,115 |
74,293,332 |
RGD:6480464 |
CTD |
| G |
Il12rb1 |
interleukin 12 receptor, beta 1 |
|
affects expression |
ISO |
16 |
19,126,653 |
19,137,584 |
RGD:6480464 |
CTD |
| G |
Il13 |
interleukin 13 |
|
affects expression |
ISO |
10 |
39,093,512 |
39,096,069 |
RGD:6480464 |
CTD |
| G |
Il1a |
interleukin 1 alpha |
|
increases expression |
ISO |
3 |
116,913,612 |
116,924,114 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
ISO |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
EXP |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
decreases expression |
EXP |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
increases expression |
ISO |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
ISO |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1r2 |
interleukin 1 receptor, type II |
|
affects expression |
ISO |
9 |
39,279,397 |
39,319,672 |
RGD:6480464 |
CTD |
| G |
Il2 |
interleukin 2 |
|
multiple interactions |
ISO |
2 |
123,655,005 |
123,659,709 |
RGD:6480464 |
CTD |
| G |
Il23a |
Interleukin 23, alpha subunit p19 |
|
affects expression |
ISO |
7 |
1,584,112 |
1,586,226 |
RGD:6480464 |
CTD |
| G |
Il2rg |
interleukin 2 receptor, gamma |
|
affects expression |
ISO |
X |
89,342,055 |
89,345,715 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
multiple interactions |
EXP |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
increases expression |
EXP |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Il6r |
interleukin 6 receptor |
|
affects expression |
ISO |
2 |
182,078,049 |
182,128,135 |
RGD:6480464 |
CTD |
| G |
Impdh2 |
IMP (inosine 5'-monophosphate) dehydrogenase 2 |
|
affects expression |
ISO |
8 |
113,607,025 |
113,611,613 |
RGD:6480464 |
CTD |
| G |
Inhba |
inhibin beta-A |
|
affects expression |
ISO |
17 |
57,244,466 |
57,257,531 |
RGD:6480464 |
CTD |
| G |
Inpp4a |
inositol polyphosphate-4-phosphatase, type I |
|
affects expression |
ISO |
9 |
36,238,645 |
36,356,933 |
RGD:6480464 |
CTD |
| G |
Insig2 |
insulin induced gene 2 |
|
affects expression |
ISO |
13 |
33,331,951 |
33,345,132 |
RGD:6480464 |
CTD |
| G |
Irf6 |
interferon regulatory factor 6 |
|
affects response to substance |
ISO |
13 |
108,986,973 |
109,006,180 |
RGD:6480464 |
CTD |
| G |
Irf6 |
interferon regulatory factor 6 |
|
affects expression |
ISO |
13 |
108,986,973 |
109,006,180 |
RGD:6480464 |
CTD |
| G |
Itga4 |
integrin, alpha 4 |
|
affects expression |
ISO |
3 |
62,024,747 |
62,097,456 |
RGD:6480464 |
CTD |
| G |
Itga6 |
integrin, alpha 6 |
|
affects expression |
ISO |
3 |
54,202,931 |
54,272,803 |
RGD:6480464 |
CTD |
| G |
Itih4 |
inter-alpha-trypsin inhibitor heavy chain family, member 4 |
|
increases expression |
EXP |
16 |
6,319,608 |
6,334,782 |
RGD:6480464 |
CTD |
| G |
Itpka |
inositol-trisphosphate 3-kinase A |
|
affects expression |
ISO |
3 |
106,257,482 |
106,266,160 |
RGD:6480464 |
CTD |
| G |
Itpr1 |
inositol 1,4,5-trisphosphate receptor, type 1 |
|
affects response to substance |
ISO |
4 |
143,705,360 |
144,030,051 |
RGD:6480464 |
CTD |
| G |
Kcmf1 |
potassium channel modulatory factor 1 |
|
affects response to substance |
ISO |
4 |
106,052,088 |
106,062,028 |
RGD:6480464 |
CTD |
| G |
Kcnc3 |
potassium voltage gated channel, Shaw-related subfamily, member 3 |
|
affects expression |
ISO |
1 |
95,066,641 |
95,080,847 |
RGD:6480464 |
CTD |
| G |
Kcne4 |
potassium voltage-gated channel, Isk-related family, member 4 |
|
affects expression |
ISO |
9 |
78,200,904 |
78,202,092 |
RGD:6480464 |
CTD |
| G |
Kcnk1 |
potassium channel, subfamily K, member 1 |
|
affects response to substance |
ISO |
19 |
56,216,600 |
56,255,299 |
RGD:6480464 |
CTD |
| G |
Kdelr1 |
KDEL (Lys-Asp-Glu-Leu) endoplasmic reticulum protein retention receptor 1 |
|
affects response to substance |
ISO |
1 |
96,348,396 |
96,359,282 |
RGD:6480464 |
CTD |
| G |
Kdm6a |
lysine (K)-specific demethylase 6A |
|
affects response to substance |
ISO |
X |
15,926,055 |
16,052,872 |
RGD:6480464 |
CTD |
| G |
Kif2c |
kinesin family member 2C |
|
decreases expression |
EXP |
5 |
137,473,698 |
137,498,974 |
RGD:6480464 |
CTD |
| G |
Kif9 |
kinesin family member 9 |
|
affects expression |
ISO |
8 |
114,867,604 |
114,906,151 |
RGD:6480464 |
CTD |
| G |
Kifap3 |
kinesin-associated protein 3 |
|
affects expression |
ISO |
13 |
79,544,010 |
79,673,768 |
RGD:6480464 |
CTD |
| G |
Klf13 |
Kruppel-like factor 13 |
|
affects expression |
ISO |
1 |
118,368,164 |
118,398,938 |
RGD:6480464 |
CTD |
| G |
Klk6 |
kallikrein related-peptidase 6 |
|
affects response to substance |
ISO |
1 |
94,254,350 |
94,261,500 |
RGD:6480464 |
CTD |
| G |
Klrc2 |
killer cell lectin-like receptor subfamily C, member 2 |
|
affects response to substance |
ISO |
4 |
166,956,614 |
166,967,757 |
RGD:6480464 |
CTD |
| G |
Klrk1 |
killer cell lectin-like receptor subfamily K, member 1 |
|
affects expression |
ISO |
4 |
166,914,786 |
166,922,659 |
RGD:6480464 |
CTD |
| G |
Kng1l1 |
kininogen 1-like 1 |
|
decreases expression |
EXP |
11 |
80,008,752 |
80,031,601 |
RGD:6480464 |
CTD |
| G |
Kng2 |
kininogen 2 |
|
increases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Kpna2 |
karyopherin alpha 2 |
|
affects expression |
ISO |
10 |
96,342,214 |
96,352,613 |
RGD:6480464 |
CTD |
| G |
Krit1 |
KRIT1, ankyrin repeat containing |
|
affects expression |
ISO |
4 |
27,014,488 |
27,048,636 |
RGD:6480464 |
CTD |
| G |
Krr1 |
KRR1, small subunit (SSU) processome component, homolog (yeast) |
|
affects response to substance |
ISO |
7 |
51,069,927 |
51,081,361 |
RGD:6480464 |
CTD |
| G |
Krt18 |
keratin 18 |
|
affects expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Krt82 |
keratin 82 |
|
affects expression |
ISO |
7 |
140,296,449 |
140,307,342 |
RGD:6480464 |
CTD |
| G |
Lamc1 |
laminin, gamma 1 |
|
affects response to substance |
ISO |
13 |
68,241,453 |
68,369,419 |
RGD:6480464 |
CTD |
| G |
Lancl2 |
LanC lantibiotic synthetase component C-like 2 (bacterial) |
|
affects expression |
ISO |
4 |
87,197,364 |
87,236,803 |
RGD:6480464 |
CTD |
| G |
Lat |
linker for activation of T cells |
|
affects expression |
ISO |
1 |
185,450,155 |
185,455,180 |
RGD:6480464 |
CTD |
| G |
Lck |
lymphocyte-specific protein tyrosine kinase |
|
affects response to substance |
ISO |
5 |
148,707,505 |
148,718,296 |
RGD:6480464 |
CTD |
| G |
Lep |
leptin |
|
affects expression |
ISO |
4 |
55,943,837 |
55,945,938 |
RGD:6480464 |
CTD |
| G |
Lgals4 |
lectin, galactoside-binding, soluble, 4 |
|
affects expression |
ISO |
1 |
83,942,899 |
83,950,613 |
RGD:6480464 |
CTD |
| G |
Lhx1 |
LIM homeobox 1 |
|
affects expression |
ISO |
10 |
72,800,497 |
72,805,799 |
RGD:6480464 |
CTD |
| G |
Lig1 |
ligase I, DNA, ATP-dependent |
|
decreases expression |
EXP |
1 |
73,728,892 |
73,767,429 |
RGD:6480464 |
CTD |
| G |
Lipc |
lipase, hepatic |
|
decreases expression |
EXP |
8 |
75,323,442 |
75,450,353 |
RGD:6480464 |
CTD |
| G |
Lix1 |
Lix1 homolog (chicken) |
|
affects expression |
ISO |
1 |
55,923,097 |
55,980,380 |
RGD:6480464 |
CTD |
| G |
Lmo1 |
LIM domain only 1 |
|
affects expression |
ISO |
1 |
166,706,025 |
166,741,550 |
RGD:6480464 |
CTD |
| G |
LOC100359600 |
karyopherin alpha 2-like |
|
affects expression |
ISO |
6 |
10,523,393 |
10,524,982 |
RGD:6480464 |
CTD |
| G |
LOC100360934 |
chordin-like 2 |
|
affects expression |
ISO |
1 |
157,391,292 |
157,411,350 |
RGD:6480464 |
CTD |
| G |
LOC100363268 |
rCG31129-like |
|
affects expression |
ISO |
2 |
189,674,857 |
189,675,177 |
RGD:6480464 |
CTD |
| G |
LOC686736 |
similar to H3 histone, family 3B |
|
affects expression |
ISO |
1 |
212,798,225 |
212,798,635 |
RGD:6480464 |
CTD |
| G |
Lpar1 |
lysophosphatidic acid receptor 1 |
|
affects response to substance |
ISO |
5 |
76,449,470 |
76,571,458 |
RGD:6480464 |
CTD |
| G |
Lpar2 |
lysophosphatidic acid receptor 2 |
|
affects response to substance |
ISO |
16 |
20,079,826 |
20,085,307 |
RGD:6480464 |
CTD |
| G |
Lphn2 |
latrophilin 2 |
|
affects response to substance |
ISO |
2 |
247,060,645 |
247,201,904 |
RGD:6480464 |
CTD |
| G |
Lpin1 |
lipin 1 |
|
affects expression |
ISO |
6 |
40,253,664 |
40,297,195 |
RGD:6480464 |
CTD |
| G |
Lpo |
lactoperoxidase |
|
affects expression |
ISO |
10 |
76,099,137 |
76,118,724 |
RGD:6480464 |
CTD |
| G |
Lrfn3 |
leucine rich repeat and fibronectin type III domain containing 3 |
|
affects expression |
ISO |
1 |
85,308,917 |
85,314,395 |
RGD:6480464 |
CTD |
| G |
Lrp6 |
low density lipoprotein receptor-related protein 6 |
|
affects expression |
ISO |
4 |
171,337,114 |
171,444,932 |
RGD:6480464 |
CTD |
| G |
Lrrc4b |
leucine rich repeat containing 4B |
|
affects expression |
ISO |
1 |
94,920,886 |
94,940,636 |
RGD:6480464 |
CTD |
| G |
Lsp1 |
lymphocyte-specific protein 1 |
|
decreases expression |
EXP |
1 |
202,707,305 |
202,741,026 |
RGD:6480464 |
CTD |
| G |
Lum |
lumican |
|
affects expression |
ISO |
7 |
35,083,480 |
35,090,284 |
RGD:6480464 |
CTD |
| G |
Ly6d |
lymphocyte antigen 6 complex, locus D |
|
affects expression |
ISO |
7 |
112,872,991 |
112,874,499 |
RGD:6480464 |
CTD |
| G |
Lztfl1 |
leucine zipper transcription factor-like 1 |
|
affects expression |
ISO |
8 |
128,474,651 |
128,489,845 |
RGD:6480464 |
CTD |
| G |
Mafb |
v-maf musculoaponeurotic fibrosarcoma oncogene homolog B (avian) |
|
affects expression |
ISO |
3 |
151,116,831 |
151,118,751 |
RGD:6480464 |
CTD |
| G |
Maged1 |
melanoma antigen, family D, 1 |
|
affects response to substance |
ISO |
X |
82,054,042 |
82,060,563 |
RGD:6480464 |
CTD |
| G |
Map2k2 |
mitogen activated protein kinase kinase 2 |
|
affects response to substance |
ISO |
7 |
10,074,654 |
10,094,003 |
RGD:6480464 |
CTD |
| G |
Map2k6 |
mitogen-activated protein kinase kinase 6 |
|
affects response to substance |
ISO |
10 |
99,859,684 |
99,974,446 |
RGD:6480464 |
CTD |
| G |
Map3k6 |
mitogen-activated protein kinase kinase kinase 6 |
|
affects expression |
ISO |
5 |
151,873,619 |
151,885,483 |
RGD:6480464 |
CTD |
| G |
Map3k9 |
mitogen-activated protein kinase kinase kinase 9 |
|
affects expression |
ISO |
6 |
105,593,215 |
105,651,838 |
RGD:6480464 |
CTD |
| G |
Map7 |
microtubule-associated protein 7 |
|
affects response to substance |
ISO |
1 |
15,440,422 |
15,553,260 |
RGD:6480464 |
CTD |
| G |
Mapk10 |
mitogen activated protein kinase 10 |
|
affects expression |
ISO |
14 |
7,719,595 |
8,010,694 |
RGD:6480464 |
CTD |
| G |
Marcks |
myristoylated alanine rich protein kinase C substrate |
|
affects expression |
ISO |
20 |
41,304,058 |
41,310,104 |
RGD:6480464 |
CTD |
| G |
Marveld2 |
MARVEL domain containing 2 |
|
affects expression |
ISO |
2 |
31,403,014 |
31,424,394 |
RGD:6480464 |
CTD |
| G |
Mbp |
myelin basic protein |
|
increases expression |
ISO |
18 |
78,943,608 |
79,057,329 |
RGD:6480464 |
CTD |
| G |
Mcf2l |
MCF.2 cell line derived transforming sequence-like |
|
affects response to substance |
ISO |
16 |
81,365,090 |
81,469,766 |
RGD:6480464 |
CTD |
| G |
Mcl1 |
myeloid cell leukemia sequence 1 |
|
affects expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Mcpt1 |
mast cell protease 1 |
|
affects expression |
ISO |
15 |
34,270,481 |
34,273,035 |
RGD:6480464 |
CTD |
| G |
Mcts1 |
malignant T cell amplified sequence 1 |
|
affects expression |
ISO |
X |
6,764,788 |
6,776,128 |
RGD:6480464 |
CTD |
| G |
Mdm2 |
p53 E3 ubiquitin protein ligase |
|
multiple interactions |
ISO |
7 |
56,996,694 |
57,020,926 |
RGD:6480464 |
CTD |
| G |
Mdm2 |
p53 E3 ubiquitin protein ligase |
|
increases expression |
ISO |
7 |
56,996,694 |
57,020,926 |
RGD:6480464 |
CTD |
| G |
Mdm2 |
p53 E3 ubiquitin protein ligase |
|
affects expression |
ISO |
7 |
56,996,694 |
57,020,926 |
RGD:6480464 |
CTD |
| G |
Med15 |
mediator complex subunit 15 |
|
affects response to substance |
ISO |
11 |
85,270,503 |
85,344,999 |
RGD:6480464 |
CTD |
| G |
Med16 |
mediator complex subunit 16 |
|
affects response to substance |
ISO |
7 |
11,311,063 |
11,323,562 |
RGD:6480464 |
CTD |
| G |
Mef2c |
myocyte enhancer factor 2C |
|
affects expression |
ISO |
2 |
12,331,078 |
12,346,520 |
RGD:6480464 |
CTD |
| G |
Megf9 |
multiple EGF-like-domains 9 |
|
affects response to substance |
ISO |
5 |
87,771,841 |
87,884,885 |
RGD:6480464 |
CTD |
| G |
Mex3b |
mex3 homolog B (C. elegans) |
|
affects expression |
ISO |
1 |
139,135,572 |
139,139,807 |
RGD:6480464 |
CTD |
| G |
Mfge8 |
milk fat globule-EGF factor 8 protein |
|
affects response to substance |
ISO |
1 |
134,870,029 |
134,885,431 |
RGD:6480464 |
CTD |
| G |
Mgat2 |
mannosyl (alpha-1,6-)-glycoprotein beta-1,2-N-acetylglucosaminyltransferase |
|
affects expression |
ISO |
6 |
91,137,262 |
91,139,751 |
RGD:6480464 |
CTD |
| G |
Mki67ip |
Mki67 (FHA domain) interacting nucleolar phosphoprotein |
|
affects expression |
ISO |
13 |
30,944,169 |
30,953,973 |
RGD:6480464 |
CTD |
| G |
Mllt10 |
myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 10 |
|
affects expression |
ISO |
17 |
92,246,466 |
92,389,861 |
RGD:6480464 |
CTD |
| G |
Mmp1b |
matrix metallopeptidase 1b (interstitial collagenase) |
|
affects expression |
ISO |
8 |
4,266,541 |
4,275,115 |
RGD:6480464 |
CTD |
| G |
Mmp3 |
matrix metallopeptidase 3 |
|
decreases expression |
ISO |
8 |
4,315,601 |
4,329,146 |
RGD:6480464 |
CTD |
| G |
Mog |
myelin oligodendrocyte glycoprotein |
|
affects expression |
ISO |
20 |
1,601,731 |
1,611,963 |
RGD:6480464 |
CTD |
| G |
Morf4l2 |
mortality factor 4 like 2 |
|
affects expression |
ISO |
X |
124,382,809 |
124,393,906 |
RGD:6480464 |
CTD |
| G |
Mphosph6-ps1 |
M phase phosphoprotein 6, pseudogene |
|
affects response to substance |
ISO |
6 |
103,512,896 |
103,513,378 |
RGD:6480464 |
CTD |
| G |
Mpo |
myeloperoxidase |
|
increases activity |
EXP |
10 |
76,085,872 |
76,097,012 |
RGD:6480464 |
CTD |
| G |
Mrgpre |
MAS-related GPR, member E |
|
affects expression |
ISO |
1 |
204,171,075 |
204,172,004 |
RGD:6480464 |
CTD |
| G |
Mrpl48 |
mitochondrial ribosomal protein L48 |
|
affects expression |
ISO |
1 |
157,979,818 |
158,022,405 |
RGD:6480464 |
CTD |
| G |
Msln |
mesothelin |
|
affects response to substance |
ISO |
10 |
15,017,162 |
15,022,823 |
RGD:6480464 |
CTD |
| G |
Msmo1 |
methylsterol monooxygenase 1 |
|
affects expression |
ISO |
16 |
26,698,324 |
26,716,247 |
RGD:6480464 |
CTD |
| G |
Mst1r |
macrophage stimulating 1 receptor (c-met-related tyrosine kinase) |
|
affects expression |
ISO |
8 |
113,175,977 |
113,189,511 |
RGD:6480464 |
CTD |
| G |
Mt1a |
metallothionein 1a |
|
increases expression |
EXP |
19 |
11,261,631 |
11,262,647 |
RGD:6480464 |
CTD |
| G |
Mthfr |
methylenetetrahydrofolate reductase (NAD(P)H) |
|
affects expression |
ISO |
5 |
165,112,850 |
165,126,885 |
RGD:6480464 |
CTD |
| G |
Mthfr |
methylenetetrahydrofolate reductase (NAD(P)H) |
|
affects response to substance |
ISO |
5 |
165,112,850 |
165,126,885 |
RGD:6480464 |
CTD |
| G |
Mthfr |
methylenetetrahydrofolate reductase (NAD(P)H) |
|
affects metabolic processing |
ISO |
5 |
165,112,850 |
165,126,885 |
RGD:6480464 |
CTD |
| G |
Mthfr |
methylenetetrahydrofolate reductase (NAD(P)H) |
|
affects response to substance |
ISO |
5 |
165,112,850 |
165,126,885 |
RGD:6480464 |
CTD |
| G |
Mthfr |
methylenetetrahydrofolate reductase (NAD(P)H) |
|
affects response to substance |
ISO |
5 |
165,112,850 |
165,126,885 |
RGD:6480464 |
CTD |
| G |
Mthfr |
methylenetetrahydrofolate reductase (NAD(P)H) |
|
decreases metabolic processing |
ISO |
5 |
165,112,850 |
165,126,885 |
RGD:6480464 |
CTD |
| G |
Mthfr |
methylenetetrahydrofolate reductase (NAD(P)H) |
|
increases response to substance |
ISO |
5 |
165,112,850 |
165,126,885 |
RGD:6480464 |
CTD |
| G |
Mthfr |
methylenetetrahydrofolate reductase (NAD(P)H) |
|
affects response to substance |
ISO |
5 |
165,112,850 |
165,126,885 |
RGD:6480464 |
CTD |
| G |
Mthfr |
methylenetetrahydrofolate reductase (NAD(P)H) |
|
affects response to substance |
ISO |
5 |
165,112,850 |
165,126,885 |
RGD:6480464 |
CTD |
| G |
Mtmr2 |
myotubularin related protein 2 |
|
affects expression |
ISO |
8 |
10,556,644 |
10,606,844 |
RGD:6480464 |
CTD |
| G |
Mtpap |
mitochondrial poly(A) polymerase |
|
affects expression |
ISO |
17 |
61,847,984 |
61,868,867 |
RGD:6480464 |
CTD |
| G |
Mtr |
5-methyltetrahydrofolate-homocysteine methyltransferase |
|
multiple interactions |
ISO |
17 |
68,782,708 |
68,867,101 |
RGD:6480464 |
CTD |
| G |
Mtr |
5-methyltetrahydrofolate-homocysteine methyltransferase |
|
decreases expression |
ISO |
17 |
68,782,708 |
68,867,101 |
RGD:6480464 |
CTD |
| G |
Mtr |
5-methyltetrahydrofolate-homocysteine methyltransferase |
|
affects metabolic processing |
ISO |
17 |
68,782,708 |
68,867,101 |
RGD:6480464 |
CTD |
| G |
Mybbp1a |
MYB binding protein (P160) 1a |
|
affects expression |
ISO |
10 |
59,325,648 |
59,335,604 |
RGD:6480464 |
CTD |
| G |
Mybl2 |
myeloblastosis oncogene-like 2 |
|
increases expression |
EXP |
3 |
153,925,908 |
153,954,323 |
RGD:6480464 |
CTD |
| G |
Mybph |
myosin binding protein H |
|
affects expression |
ISO |
13 |
47,151,091 |
47,158,665 |
RGD:6480464 |
CTD |
| G |
Myct1 |
myc target 1 |
|
affects expression |
ISO |
1 |
36,314,335 |
36,325,608 |
RGD:6480464 |
CTD |
| G |
Myl1 |
myosin, light chain 1 |
|
affects expression |
ISO |
9 |
65,717,097 |
65,737,576 |
RGD:6480464 |
CTD |
| G |
Myo1e |
myosin IE |
|
affects response to substance |
ISO |
8 |
74,680,727 |
74,884,376 |
RGD:6480464 |
CTD |
| G |
Myo6 |
myosin VI |
|
affects response to substance |
ISO |
8 |
85,203,987 |
85,368,026 |
RGD:6480464 |
CTD |
| G |
Nampt |
nicotinamide phosphoribosyltransferase |
|
affects expression |
ISO |
6 |
51,129,160 |
51,166,514 |
RGD:6480464 |
CTD |
| G |
Nat1 |
N-acetyltransferase 1 (arylamine N-acetyltransferase) |
|
decreases activity |
ISO |
16 |
23,845,894 |
23,876,528 |
RGD:6480464 |
CTD |
| G |
Ncoa2 |
nuclear receptor coactivator 2 |
|
affects expression |
ISO |
5 |
5,197,891 |
5,275,776 |
RGD:6480464 |
CTD |
| G |
Ncoa3 |
nuclear receptor coactivator 3 |
|
affects expression |
ISO |
3 |
157,168,492 |
157,196,566 |
RGD:6480464 |
CTD |
| G |
Ncoa4 |
nuclear receptor coactivator 4 |
|
affects expression |
ISO |
16 |
7,642,116 |
7,662,460 |
RGD:6480464 |
CTD |
| G |
Ncoa5 |
nuclear receptor coactivator 5 |
|
affects expression |
ISO |
3 |
156,038,570 |
156,071,702 |
RGD:6480464 |
CTD |
| G |
Ndufs5 |
NADH dehydrogenase (ubiquinone) Fe-S protein 5 |
|
affects expression |
ISO |
5 |
143,017,421 |
143,023,425 |
RGD:6480464 |
CTD |
| G |
Ndufs8 |
NADH dehydrogenase (ubiquinone) Fe-S protein 8 |
|
affects response to substance |
ISO |
1 |
206,433,596 |
206,437,478 |
RGD:6480464 |
CTD |
| G |
Nek6 |
NIMA-related kinase 6 |
|
increases expression |
EXP |
3 |
18,348,698 |
18,381,895 |
RGD:6480464 |
CTD |
| G |
Nelfa |
negative elongation factor complex member A |
|
affects expression |
ISO |
14 |
82,502,840 |
82,526,916 |
RGD:6480464 |
CTD |
| G |
Net1 |
neuroepithelial cell transforming 1 |
|
affects expression |
ISO |
17 |
77,533,225 |
77,543,337 |
RGD:6480464 |
CTD |
| G |
Nfe2l1 |
nuclear factor, erythroid derived 2,-like 1 |
|
affects response to substance |
ISO |
10 |
85,570,238 |
85,577,636 |
RGD:6480464 |
CTD |
| G |
Nfkb2 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 2, p49/p100 |
|
affects response to substance |
ISO |
1 |
251,521,559 |
251,527,815 |
RGD:6480464 |
CTD |
| G |
Nfya |
nuclear transcription factor-Y alpha |
|
affects expression |
ISO |
9 |
7,970,040 |
7,994,375 |
RGD:6480464 |
CTD |
| G |
Ngef |
neuronal guanine nucleotide exchange factor |
|
decreases expression |
EXP |
9 |
86,294,206 |
86,327,765 |
RGD:6480464 |
CTD |
| G |
Nhlrc1 |
NHL repeat containing 1 |
|
affects expression |
ISO |
17 |
23,726,054 |
23,727,244 |
RGD:6480464 |
CTD |
| G |
Nid2 |
nidogen 2 (osteonidogen) |
|
affects expression |
ISO |
15 |
4,801,183 |
4,856,895 |
RGD:6480464 |
CTD |
| G |
Nid2 |
nidogen 2 (osteonidogen) |
|
decreases expression |
EXP |
15 |
4,801,183 |
4,856,895 |
RGD:6480464 |
CTD |
| G |
Nkd2 |
naked cuticle homolog 2 (Drosophila) |
|
affects expression |
ISO |
1 |
30,252,093 |
30,278,933 |
RGD:6480464 |
CTD |
| G |
Nlrp5 |
NLR family, pyrin domain containing 5 |
|
affects expression |
ISO |
1 |
66,212,857 |
66,246,286 |
RGD:6480464 |
CTD |
| G |
Nog |
noggin |
|
affects expression |
ISO |
10 |
77,689,244 |
77,690,871 |
RGD:6480464 |
CTD |
| G |
Nol3 |
nucleolar protein 3 (apoptosis repressor with CARD domain) |
|
affects expression |
ISO |
19 |
35,094,345 |
35,096,012 |
RGD:6480464 |
CTD |
| G |
Nol6 |
nucleolar protein 6 (RNA-associated) |
|
affects expression |
ISO |
5 |
58,523,391 |
58,533,113 |
RGD:6480464 |
CTD |
| G |
Nolc1 |
nucleolar and coiled-body phosphoprotein 1 |
|
affects expression |
ISO |
1 |
251,297,417 |
251,308,127 |
RGD:6480464 |
CTD |
| G |
Nop56 |
NOP56 ribonucleoprotein |
|
affects expression |
ISO |
3 |
117,887,822 |
117,892,614 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
multiple interactions |
ISO |
10 |
65,036,884 |
65,072,453 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
decreases activity |
EXP |
10 |
65,036,884 |
65,072,453 |
RGD:6480464 |
CTD |
| G |
Nos3 |
nitric oxide synthase 3, endothelial cell |
|
affects response to substance |
ISO |
4 |
6,158,847 |
6,179,441 |
RGD:6480464 |
CTD |
| G |
Notch3 |
notch 3 |
|
affects expression |
ISO |
7 |
12,688,267 |
12,740,015 |
RGD:6480464 |
CTD |
| G |
Npr1 |
natriuretic peptide receptor A/guanylate cyclase A (atrionatriuretic peptide receptor A) |
|
decreases expression |
EXP |
2 |
182,724,916 |
182,740,242 |
RGD:6480464 |
CTD |
| G |
Nqo1 |
NAD(P)H dehydrogenase, quinone 1 |
|
decreases expression |
EXP |
19 |
37,251,147 |
37,266,040 |
RGD:6480464 |
CTD |
| G |
Nr1h4 |
nuclear receptor subfamily 1, group H, member 4 |
|
decreases expression |
EXP |
7 |
26,189,759 |
26,307,061 |
RGD:6480464 |
CTD |
| G |
Nr1i2 |
nuclear receptor subfamily 1, group I, member 2 |
|
decreases expression |
EXP |
11 |
64,239,918 |
64,276,702 |
RGD:6480464 |
CTD |
| G |
Nr1i3 |
nuclear receptor subfamily 1, group I, member 3 |
|
decreases expression |
EXP |
13 |
87,104,241 |
87,108,563 |
RGD:6480464 |
CTD |
| G |
Nradd |
neurotrophin receptor associated death domain |
|
affects expression |
ISO |
8 |
115,002,319 |
115,005,292 |
RGD:6480464 |
CTD |
| G |
Nrg4 |
neuregulin 4 |
|
affects expression |
ISO |
8 |
58,764,526 |
58,830,666 |
RGD:6480464 |
CTD |
| G |
Nrxn1 |
neurexin 1 |
|
affects expression |
ISO |
6 |
14,050,929 |
15,354,069 |
RGD:6480464 |
CTD |
| G |
Nsd1 |
nuclear receptor binding SET domain protein 1 |
|
affects expression |
ISO |
17 |
15,362,482 |
15,471,961 |
RGD:6480464 |
CTD |
| G |
Nup88 |
nucleoporin 88 |
|
affects response to substance |
ISO |
10 |
57,849,428 |
57,874,078 |
RGD:6480464 |
CTD |
| G |
Nupl1 |
nucleoporin like 1 |
|
affects expression |
ISO |
15 |
39,317,826 |
39,350,075 |
RGD:6480464 |
CTD |
| G |
Nupl2 |
nucleoporin like 2 |
|
affects expression |
ISO |
4 |
6,352,149 |
6,369,568 |
RGD:6480464 |
CTD |
| G |
Nutm1 |
NUT midline carcinoma, family member 1 |
|
affects expression |
ISO |
3 |
98,091,935 |
98,102,736 |
RGD:6480464 |
CTD |
| G |
Nvl |
nuclear VCP-like |
|
affects expression |
ISO |
13 |
96,862,759 |
96,917,215 |
RGD:6480464 |
CTD |
| G |
Oas1h |
2 ' -5 ' oligoadenylate synthetase 1H |
|
affects expression |
ISO |
12 |
36,819,920 |
36,829,587 |
RGD:6480464 |
CTD |
| G |
Oat |
ornithine aminotransferase |
|
affects expression |
ISO |
1 |
192,026,623 |
192,046,404 |
RGD:6480464 |
CTD |
| G |
Obp3 |
alpha-2u globulin PGCL4 |
|
decreases expression |
EXP |
5 |
78,088,876 |
78,092,317 |
RGD:6480464 |
CTD |
| G |
Ocln |
occludin |
|
affects expression |
ISO |
2 |
31,317,090 |
31,367,485 |
RGD:6480464 |
CTD |
| G |
Odc1 |
ornithine decarboxylase 1 |
|
increases expression |
ISO |
6 |
41,309,211 |
41,315,796 |
RGD:6480464 |
CTD |
| G |
Olr1006 |
olfactory receptor 1006 |
|
affects expression |
ISO |
7 |
6,592,173 |
6,593,123 |
RGD:6480464 |
CTD |
| G |
Olr1143 |
olfactory receptor 1143 |
|
affects expression |
ISO |
8 |
17,446,743 |
17,447,681 |
RGD:6480464 |
CTD |
| G |
Olr1165 |
olfactory receptor 1165 |
|
affects expression |
ISO |
8 |
18,409,682 |
18,410,611 |
RGD:6480464 |
CTD |
| G |
Olr1169 |
olfactory receptor 1169 |
|
affects expression |
ISO |
8 |
18,544,843 |
18,545,799 |
RGD:6480464 |
CTD |
| G |
Olr1230 |
olfactory receptor 1230 |
|
affects expression |
ISO |
8 |
40,493,892 |
40,494,833 |
RGD:6480464 |
CTD |
| G |
Olr1234 |
olfactory receptor 1234 |
|
affects expression |
ISO |
8 |
40,544,443 |
40,545,384 |
RGD:6480464 |
CTD |
| G |
Olr1252 |
olfactory receptor 1252 |
|
affects expression |
ISO |
8 |
40,771,052 |
40,771,984 |
RGD:6480464 |
CTD |
| G |
Olr1307 |
olfactory receptor 1307 |
|
affects expression |
ISO |
8 |
42,437,236 |
42,438,171 |
RGD:6480464 |
CTD |
| G |
Olr1329 |
olfactory receptor 1329 |
|
affects expression |
ISO |
8 |
42,872,636 |
42,873,568 |
RGD:6480464 |
CTD |
| G |
Olr1413 |
olfactory receptor 1413 |
|
affects expression |
ISO |
10 |
44,095,885 |
44,096,832 |
RGD:6480464 |
CTD |
| G |
Olr1432 |
olfactory receptor 1432 |
|
affects expression |
ISO |
10 |
44,488,968 |
44,489,939 |
RGD:6480464 |
CTD |
| G |
Olr160 |
olfactory receptor 160 |
|
affects expression |
ISO |
1 |
162,309,727 |
162,310,695 |
RGD:6480464 |
CTD |
| G |
Olr161 |
olfactory receptor 161 |
|
affects expression |
ISO |
1 |
162,319,179 |
162,320,138 |
RGD:6480464 |
CTD |
| G |
Olr185 |
olfactory receptor 185 |
|
affects expression |
ISO |
1 |
162,803,635 |
162,804,588 |
RGD:6480464 |
CTD |
| G |
Olr272 |
olfactory receptor 272 |
|
affects expression |
ISO |
1 |
166,018,909 |
166,019,853 |
RGD:6480464 |
CTD |
| G |
Olr295 |
olfactory receptor 295 |
|
affects expression |
ISO |
1 |
200,296,473 |
200,297,405 |
RGD:6480464 |
CTD |
| G |
Olr465 |
olfactory receptor 465 |
|
affects expression |
ISO |
3 |
69,117,077 |
69,118,024 |
RGD:6480464 |
CTD |
| G |
Olr559 |
olfactory receptor 559 |
|
affects expression |
ISO |
3 |
71,006,856 |
71,007,800 |
RGD:6480464 |
CTD |
| G |
Olr601 |
olfactory receptor 601 |
|
affects expression |
ISO |
3 |
71,714,539 |
71,715,492 |
RGD:6480464 |
CTD |
| G |
Olr707 |
olfactory receptor 707 |
|
affects expression |
ISO |
3 |
74,001,874 |
74,002,797 |
RGD:6480464 |
CTD |
| G |
Olr737 |
olfactory receptor 737 |
|
affects expression |
ISO |
3 |
74,612,307 |
74,613,233 |
RGD:6480464 |
CTD |
| G |
Olr982 |
olfactory receptor 982 |
|
affects expression |
ISO |
7 |
5,825,103 |
5,826,038 |
RGD:6480464 |
CTD |
| G |
Orc4 |
origin recognition complex, subunit 4 |
|
affects expression |
ISO |
3 |
29,813,264 |
29,851,852 |
RGD:6480464 |
CTD |
| G |
Orm1 |
orosomucoid 1 |
|
increases expression |
EXP |
5 |
80,325,042 |
80,328,194 |
RGD:6480464 |
CTD |
| G |
Orm1 |
orosomucoid 1 |
|
increases expression |
EXP |
5 |
80,325,042 |
80,328,194 |
RGD:6480464 |
CTD |
| G |
Osbpl8 |
oxysterol binding protein-like 8 |
|
affects expression |
ISO |
7 |
50,308,713 |
50,313,369 |
RGD:6480464 |
CTD |
| G |
P2rx2 |
purinergic receptor P2X, ligand-gated ion channel, 2 |
|
affects expression |
ISO |
12 |
46,485,125 |
46,488,319 |
RGD:6480464 |
CTD |
| G |
P4ha1 |
prolyl 4-hydroxylase, alpha polypeptide I |
|
affects expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
P4hb |
prolyl 4-hydroxylase, beta polypeptide |
|
affects response to substance |
ISO |
10 |
109,950,221 |
109,961,716 |
RGD:6480464 |
CTD |
| G |
Pabpc4 |
poly(A) binding protein, cytoplasmic 4 |
|
affects expression |
ISO |
5 |
142,599,706 |
142,615,003 |
RGD:6480464 |
CTD |
| G |
Papola |
poly (A) polymerase alpha |
|
affects response to substance |
ISO |
6 |
129,936,041 |
129,988,481 |
RGD:6480464 |
CTD |
| G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
|
increases cleavage |
ISO |
13 |
96,309,670 |
96,341,486 |
RGD:6480464 |
CTD |
| G |
Parvb |
parvin, beta |
|
affects expression |
ISO |
7 |
122,223,325 |
122,310,356 |
RGD:6480464 |
CTD |
| G |
Pbx2 |
pre-B-cell leukemia homeobox 2 |
|
affects expression |
ISO |
20 |
4,253,962 |
4,259,185 |
RGD:6480464 |
CTD |
| G |
Pcdhb22 |
protocadherin beta 22 |
|
affects expression |
ISO |
18 |
30,327,386 |
30,330,048 |
RGD:6480464 |
CTD |
| G |
Pcolce |
procollagen C-endopeptidase enhancer |
|
affects expression |
ISO |
12 |
19,672,505 |
19,678,821 |
RGD:6480464 |
CTD |
| G |
Pcsk4 |
proprotein convertase subtilisin/kexin type 4 |
|
affects expression |
ISO |
7 |
10,892,705 |
10,900,928 |
RGD:6480464 |
CTD |
| G |
Pcyt1a |
phosphate cytidylyltransferase 1, choline, alpha |
|
increases expression |
EXP |
11 |
70,133,325 |
70,173,686 |
RGD:6480464 |
CTD |
| G |
Pcyt1b |
phosphate cytidylyltransferase 1, choline, beta |
|
affects expression |
ISO |
X |
81,023,064 |
81,087,051 |
RGD:6480464 |
CTD |
| G |
Pdcd11 |
programmed cell death 11 |
|
affects expression |
ISO |
1 |
252,413,500 |
252,454,620 |
RGD:6480464 |
CTD |
| G |
Pde1b |
phosphodiesterase 1B, calmodulin-dependent |
|
affects expression |
ISO |
7 |
142,401,489 |
142,427,626 |
RGD:6480464 |
CTD |
| G |
Pde4b |
phosphodiesterase 4B, cAMP specific |
|
affects expression |
ISO |
5 |
123,158,156 |
123,533,877 |
RGD:6480464 |
CTD |
| G |
Pdk1 |
pyruvate dehydrogenase kinase, isozyme 1 |
|
affects response to substance |
ISO |
3 |
54,292,076 |
54,319,242 |
RGD:6480464 |
CTD |
| G |
Pdk4 |
pyruvate dehydrogenase kinase, isozyme 4 |
|
affects expression |
ISO |
4 |
30,235,296 |
30,245,298 |
RGD:6480464 |
CTD |
| G |
Pdlim2 |
PDZ and LIM domain 2 |
|
affects expression |
ISO |
15 |
50,564,108 |
50,575,871 |
RGD:6480464 |
CTD |
| G |
Pdlim7 |
PDZ and LIM domain 7 |
|
affects response to substance |
ISO |
17 |
15,168,835 |
15,183,983 |
RGD:6480464 |
CTD |
| G |
Per1 |
period circadian clock 1 |
|
affects expression |
ISO |
10 |
55,859,851 |
55,868,747 |
RGD:6480464 |
CTD |
| G |
Per2 |
period circadian clock 2 |
|
affects response to substance |
ISO |
9 |
90,645,342 |
90,687,509 |
RGD:6480464 |
CTD |
| G |
Per2 |
period circadian clock 2 |
|
affects expression |
ISO |
9 |
90,645,342 |
90,687,509 |
RGD:6480464 |
CTD |
| G |
Pes1 |
pescadillo ribosomal biogenesis factor 1 |
|
affects expression |
ISO |
14 |
84,616,451 |
84,632,831 |
RGD:6480464 |
CTD |
| G |
Pex11a |
peroxisomal biogenesis factor 11 alpha |
|
affects response to substance |
ISO |
1 |
135,513,735 |
135,520,816 |
RGD:6480464 |
CTD |
| G |
Pgm5 |
phosphoglucomutase 5 |
|
affects expression |
ISO |
1 |
228,107,411 |
228,300,939 |
RGD:6480464 |
CTD |
| G |
Phactr2 |
phosphatase and actin regulator 2 |
|
affects response to substance |
ISO |
1 |
7,988,527 |
8,102,667 |
RGD:6480464 |
CTD |
| G |
Phf10 |
PHD finger protein 10 |
|
affects response to substance |
ISO |
1 |
53,874,298 |
53,890,546 |
RGD:6480464 |
CTD |
| G |
Phf12 |
PHD finger protein 12 |
|
affects expression |
ISO |
10 |
64,024,531 |
64,074,458 |
RGD:6480464 |
CTD |
| G |
Phf7 |
PHD finger protein 7 |
|
affects expression |
ISO |
16 |
6,671,312 |
6,684,015 |
RGD:6480464 |
CTD |
| G |
Phf8 |
PHD finger protein 8 |
|
affects expression |
ISO |
X |
40,869,942 |
40,970,244 |
RGD:6480464 |
CTD |
| G |
Phkb |
phosphorylase kinase, beta |
|
affects expression |
ISO |
19 |
22,373,355 |
22,561,509 |
RGD:6480464 |
CTD |
| G |
Pick1 |
protein interacting with PRKCA 1 |
|
affects expression |
ISO |
7 |
117,213,299 |
117,232,651 |
RGD:6480464 |
CTD |
| G |
Pigb |
phosphatidylinositol glycan anchor biosynthesis, class B |
|
affects expression |
ISO |
8 |
77,767,438 |
77,791,780 |
RGD:6480464 |
CTD |
| G |
Pik3c2b |
phosphatidylinositol-4-phosphate 3-kinase, catalytic subunit type 2 beta |
|
affects response to substance |
ISO |
13 |
45,954,337 |
46,013,206 |
RGD:6480464 |
CTD |
| G |
Pik3r1 |
phosphoinositide-3-kinase, regulatory subunit 1 (alpha) |
|
affects expression |
ISO |
2 |
32,602,673 |
32,675,350 |
RGD:6480464 |
CTD |
| G |
Pin1 |
peptidylprolyl cis/trans isomerase, NIMA-interacting 1 |
|
affects response to substance |
ISO |
8 |
19,669,537 |
19,681,741 |
RGD:6480464 |
CTD |
| G |
Pitpnm2 |
phosphatidylinositol transfer protein, membrane-associated 2 |
|
affects expression |
ISO |
12 |
33,496,702 |
33,603,240 |
RGD:6480464 |
CTD |
| G |
Pkd2l2 |
polycystic kidney disease 2-like 2 |
|
affects expression |
ISO |
18 |
26,876,459 |
26,911,433 |
RGD:6480464 |
CTD |
| G |
Pkp2 |
plakophilin 2 |
|
increases expression |
EXP |
11 |
86,553,493 |
86,584,425 |
RGD:6480464 |
CTD |
| G |
Pla2g2c |
phospholipase A2, group IIC |
|
affects expression |
ISO |
5 |
157,536,546 |
157,555,895 |
RGD:6480464 |
CTD |
| G |
Pld3 |
phospholipase D family, member 3 |
|
affects response to substance |
ISO |
1 |
82,612,833 |
82,624,575 |
RGD:6480464 |
CTD |
| G |
Plekhj1 |
pleckstrin homology domain containing, family J member 1 |
|
affects expression |
ISO |
7 |
10,426,511 |
10,428,646 |
RGD:6480464 |
CTD |
| G |
Plin2 |
perilipin 2 |
|
affects expression |
ISO |
5 |
105,718,496 |
105,732,817 |
RGD:6480464 |
CTD |
| G |
Plk4 |
polo-like kinase 4 |
|
affects expression |
ISO |
2 |
127,760,508 |
127,779,640 |
RGD:6480464 |
CTD |
| G |
Pln |
phospholamban |
|
affects expression |
ISO |
20 |
32,000,371 |
32,008,559 |
RGD:6480464 |
CTD |
| G |
Pltp |
phospholipid transfer protein |
|
affects expression |
ISO |
3 |
155,871,842 |
155,889,959 |
RGD:6480464 |
CTD |
| G |
Pltp |
phospholipid transfer protein |
|
decreases expression |
ISO |
3 |
155,871,842 |
155,889,959 |
RGD:6480464 |
CTD |
| G |
Plxna2 |
plexin A2 |
|
affects expression |
ISO |
13 |
110,555,958 |
110,754,672 |
RGD:6480464 |
CTD |
| G |
Pmf1 |
polyamine-modulated factor 1 |
|
affects expression |
ISO |
2 |
180,492,380 |
180,511,936 |
RGD:6480464 |
CTD |
| G |
Pms1 |
postmeiotic segregation increased 1 (S. cerevisiae) |
|
affects expression |
ISO |
9 |
45,203,344 |
45,292,624 |
RGD:6480464 |
CTD |
| G |
Pnlip |
pancreatic lipase |
|
affects expression |
ISO |
1 |
265,107,812 |
265,120,969 |
RGD:6480464 |
CTD |
| G |
Pnliprp2 |
pancreatic lipase-related protein 2 |
|
affects expression |
ISO |
1 |
265,267,609 |
265,285,920 |
RGD:6480464 |
CTD |
| G |
Pnma2 |
paraneoplastic Ma antigen 2 |
|
affects response to substance |
ISO |
15 |
46,452,913 |
46,460,573 |
RGD:6480464 |
CTD |
| G |
Pnpla2 |
patatin-like phospholipase domain containing 2 |
|
increases expression |
EXP |
1 |
201,641,939 |
201,647,021 |
RGD:6480464 |
CTD |
| G |
Polr1b |
polymerase (RNA) I polypeptide B |
|
affects expression |
ISO |
3 |
116,706,483 |
116,730,946 |
RGD:6480464 |
CTD |
| G |
Polr1e |
polymerase (RNA) I polypeptide E |
|
affects expression |
ISO |
5 |
61,581,916 |
61,598,266 |
RGD:6480464 |
CTD |
| G |
Pon1 |
paraoxonase 1 |
|
decreases expression |
EXP |
4 |
29,936,314 |
29,964,821 |
RGD:6480464 |
CTD |
| G |
Por |
P450 (cytochrome) oxidoreductase |
|
affects expression |
ISO |
12 |
22,078,629 |
22,097,301 |
RGD:6480464 |
CTD |
| G |
Ppan |
peter pan homolog (Drosophila) |
|
affects expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Ppap2a |
phosphatidic acid phosphatase type 2A |
|
affects response to substance |
ISO |
2 |
44,183,290 |
44,247,787 |
RGD:6480464 |
CTD |
| G |
Ppat |
phosphoribosyl pyrophosphate amidotransferase |
|
affects expression |
ISO |
14 |
33,509,364 |
33,543,743 |
RGD:6480464 |
CTD |
| G |
Ppid |
peptidylprolyl isomerase D |
|
affects response to substance |
ISO |
2 |
170,995,919 |
171,007,932 |
RGD:6480464 |
CTD |
| G |
Ppif |
peptidylprolyl isomerase F |
|
affects expression |
ISO |
16 |
1,292,835 |
1,299,556 |
RGD:6480464 |
CTD |
| G |
Ppp1r1b |
protein phosphatase 1, regulatory (inhibitor) subunit 1B |
|
affects expression |
ISO |
10 |
87,121,889 |
87,131,587 |
RGD:6480464 |
CTD |
| G |
Ppp1r3c |
protein phosphatase 1, regulatory subunit 3C |
|
affects expression |
ISO |
1 |
240,991,884 |
240,996,887 |
RGD:6480464 |
CTD |
| G |
Ppp2r5c |
protein phosphatase 2, regulatory subunit B', gamma |
|
affects response to substance |
ISO |
6 |
135,204,405 |
135,299,068 |
RGD:6480464 |
CTD |
| G |
Ppp3ca |
protein phosphatase 3, catalytic subunit, alpha isozyme |
|
affects response to substance |
ISO |
2 |
234,130,176 |
234,409,232 |
RGD:6480464 |
CTD |
| G |
Pprc1 |
peroxisome proliferator-activated receptor gamma, coactivator-related 1 |
|
affects response to substance |
ISO |
1 |
251,278,222 |
251,294,628 |
RGD:6480464 |
CTD |
| G |
Prc1 |
protein regulator of cytokinesis 1 |
|
decreases expression |
ISO |
1 |
136,112,674 |
136,133,720 |
RGD:6480464 |
CTD |
| G |
Prkcb |
protein kinase C, beta |
|
increases expression |
EXP |
1 |
181,117,512 |
181,459,856 |
RGD:6480464 |
CTD |
| G |
Prkce |
protein kinase C, epsilon |
|
affects expression |
ISO |
6 |
9,631,234 |
10,097,311 |
RGD:6480464 |
CTD |
| G |
Prph |
peripherin |
|
decreases expression |
EXP |
7 |
137,836,152 |
137,839,931 |
RGD:6480464 |
CTD |
| G |
Prps2 |
phosphoribosyl pyrophosphate synthetase 2 |
|
affects expression |
ISO |
X |
47,274,362 |
47,315,274 |
RGD:6480464 |
CTD |
| G |
Psap |
prosaposin |
|
affects response to substance |
ISO |
20 |
27,595,048 |
27,621,574 |
RGD:6480464 |
CTD |
| G |
Psmc5 |
proteasome (prosome, macropain) 26S subunit, ATPase, 5 |
|
affects expression |
ISO |
10 |
95,650,987 |
95,656,921 |
RGD:6480464 |
CTD |
| G |
Psmd12 |
proteasome (prosome, macropain) 26S subunit, non-ATPase, 12 |
|
affects expression |
ISO |
10 |
96,881,373 |
96,907,258 |
RGD:6480464 |
CTD |
| G |
Psme3 |
proteasome (prosome, macropain) activator subunit 3 |
|
affects expression |
ISO |
10 |
90,343,493 |
90,351,335 |
RGD:6480464 |
CTD |
| G |
Pth2r |
parathyroid hormone 2 receptor |
|
decreases expression |
EXP |
9 |
63,942,380 |
64,049,405 |
RGD:6480464 |
CTD |
| G |
Ptk7 |
protein tyrosine kinase 7 |
|
affects expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Ptov1 |
prostate tumor overexpressed 1 |
|
affects response to substance |
ISO |
1 |
95,335,898 |
95,342,444 |
RGD:6480464 |
CTD |
| G |
Ptprg |
protein tyrosine phosphatase, receptor type, G |
|
affects response to substance |
ISO |
15 |
14,449,352 |
15,130,760 |
RGD:6480464 |
CTD |
| G |
Ptprj |
protein tyrosine phosphatase, receptor type, J |
|
affects expression |
ISO |
3 |
74,796,764 |
74,935,540 |
RGD:6480464 |
CTD |
| G |
Ptprr |
protein tyrosine phosphatase, receptor type, R |
|
affects expression |
ISO |
7 |
55,324,246 |
55,612,945 |
RGD:6480464 |
CTD |
| G |
Pvrl2 |
poliovirus receptor-related 2 |
|
affects response to substance |
ISO |
1 |
79,021,831 |
79,059,686 |
RGD:6480464 |
CTD |
| G |
Pvrl2 |
poliovirus receptor-related 2 |
|
affects expression |
ISO |
1 |
79,021,831 |
79,059,686 |
RGD:6480464 |
CTD |
| G |
Qdpr |
quinoid dihydropteridine reductase |
|
decreases activity |
ISO |
14 |
70,741,998 |
70,755,600 |
RGD:6480464 |
CTD |
| G |
Rab11fip2 |
RAB11 family interacting protein 2 (class I) |
|
affects response to substance |
ISO |
1 |
266,461,752 |
266,497,576 |
RGD:6480464 |
CTD |
| G |
Rab1a |
RAB1A, member RAS oncogene family |
|
affects response to substance |
ISO |
14 |
100,973,039 |
101,027,893 |
RGD:6480464 |
CTD |
| G |
Rabep2 |
rabaptin, RAB GTPase binding effector protein 2 |
|
affects expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Ran |
RAN, member RAS oncogene family |
|
affects expression |
ISO |
12 |
28,736,786 |
28,739,921 |
RGD:6480464 |
CTD |
| G |
Rasgrp2 |
RAS guanyl releasing protein 2 (calcium and DAG-regulated) |
|
affects expression |
ISO |
1 |
209,183,700 |
209,199,170 |
RGD:6480464 |
CTD |
| G |
Rb1 |
retinoblastoma 1 |
|
affects response to substance |
ISO |
15 |
53,828,881 |
53,962,099 |
RGD:6480464 |
CTD |
| G |
Rb1 |
retinoblastoma 1 |
|
affects response to substance |
ISO |
15 |
53,828,881 |
53,962,099 |
RGD:6480464 |
CTD |
| G |
Rb1 |
retinoblastoma 1 |
|
increases response to substance |
ISO |
15 |
53,828,881 |
53,962,099 |
RGD:6480464 |
CTD |
| G |
Rbak |
RB-associated KRAB zinc finger |
|
affects expression |
ISO |
12 |
11,748,333 |
11,760,544 |
RGD:6480464 |
CTD |
| G |
Rbm10 |
RNA binding motif protein 10 |
|
affects expression |
ISO |
X |
12,957,747 |
12,989,619 |
RGD:6480464 |
CTD |
| G |
Rbms1 |
RNA binding motif, single stranded interacting protein 1 |
|
affects response to substance |
ISO |
3 |
42,438,537 |
42,663,729 |
RGD:6480464 |
CTD |
| G |
Rbms2 |
RNA binding motif, single stranded interacting protein 2 |
|
affects expression |
ISO |
7 |
1,426,634 |
1,462,518 |
RGD:6480464 |
CTD |
| G |
Reg4 |
regenerating islet-derived family, member 4 |
|
affects expression |
ISO |
2 |
193,066,427 |
193,077,988 |
RGD:6480464 |
CTD |
| G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
increases expression |
EXP |
1 |
208,262,669 |
208,273,148 |
RGD:6480464 |
CTD |
| G |
Relb |
v-rel reticuloendotheliosis viral oncogene homolog B |
|
affects expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Relt |
RELT tumor necrosis factor receptor |
|
affects expression |
ISO |
1 |
158,293,361 |
158,300,581 |
RGD:6480464 |
CTD |
| G |
Rem2 |
RAS (RAD and GEM) like GTP binding 2 |
|
affects expression |
ISO |
15 |
32,539,996 |
32,544,475 |
RGD:6480464 |
CTD |
| G |
Repin1 |
replication initiator 1 |
|
affects expression |
ISO |
4 |
76,688,429 |
76,690,141 |
RGD:6480464 |
CTD |
| G |
Rfc3 |
replication factor C (activator 1) 3 |
|
decreases expression |
EXP |
12 |
3,224,493 |
3,235,256 |
RGD:6480464 |
CTD |
| G |
Rgs13 |
regulator of G-protein signaling 13 |
|
affects expression |
ISO |
13 |
58,016,245 |
58,042,762 |
RGD:6480464 |
CTD |
| G |
Rhoj |
ras homolog family member J |
|
affects expression |
ISO |
6 |
97,911,744 |
97,995,878 |
RGD:6480464 |
CTD |
| G |
Rhpn2 |
rhophilin, Rho GTPase binding protein 2 |
|
affects expression |
ISO |
1 |
87,853,620 |
87,917,634 |
RGD:6480464 |
CTD |
| G |
Rims2 |
regulating synaptic membrane exocytosis 2 |
|
affects expression |
ISO |
7 |
74,757,003 |
75,271,771 |
RGD:6480464 |
CTD |
| G |
Riok2 |
RIO kinase 2 |
|
affects expression |
ISO |
1 |
55,897,247 |
55,913,533 |
RGD:6480464 |
CTD |
| G |
Rnf150 |
ring finger protein 150 |
|
affects expression |
ISO |
19 |
26,737,910 |
26,962,470 |
RGD:6480464 |
CTD |
| G |
Rora |
RAR-related orphan receptor A |
|
affects expression |
ISO |
8 |
73,052,282 |
73,817,764 |
RGD:6480464 |
CTD |
| G |
Rora |
RAR-related orphan receptor A |
|
affects expression |
ISO |
8 |
73,052,282 |
73,817,764 |
RGD:6480464 |
CTD |
| G |
Rpl21 |
ribosomal protein L21 |
|
affects expression |
ISO |
12 |
8,716,675 |
8,719,754 |
RGD:6480464 |
CTD |
| G |
Rpl23a |
ribosomal protein L23a |
|
affects response to substance |
ISO |
10 |
64,451,931 |
64,454,617 |
RGD:6480464 |
CTD |
| G |
Rpl37 |
ribosomal protein L37 |
|
affects expression |
ISO |
2 |
54,302,355 |
54,304,308 |
RGD:6480464 |
CTD |
| G |
Rplp1 |
ribosomal protein, large, P1 |
|
affects expression |
ISO |
8 |
66,046,220 |
66,047,553 |
RGD:6480464 |
CTD |
| G |
Rps19 |
ribosomal protein S19 |
|
affects expression |
ISO |
1 |
80,176,649 |
80,182,351 |
RGD:6480464 |
CTD |
| G |
Rps2 |
ribosomal protein S2 |
|
affects expression |
ISO |
10 |
13,975,350 |
13,977,199 |
RGD:6480464 |
CTD |
| G |
Rps6ka3 |
ribosomal protein S6 kinase polypeptide 3 |
|
affects expression |
ISO |
X |
56,722,878 |
56,825,444 |
RGD:6480464 |
CTD |
| G |
Rps6ka4 |
ribosomal protein S6 kinase, polypeptide 4 |
|
affects expression |
ISO |
1 |
209,505,327 |
209,516,071 |
RGD:6480464 |
CTD |
| G |
Rps6kb1 |
ribosomal protein S6 kinase, polypeptide 1 |
|
increases expression |
EXP |
10 |
76,657,024 |
76,698,088 |
RGD:6480464 |
CTD |
| G |
Rrh |
retinal pigment epithelium derived rhodopsin homolog |
|
affects expression |
ISO |
2 |
227,256,627 |
227,266,897 |
RGD:6480464 |
CTD |
| G |
Rrm2 |
ribonucleotide reductase M2 |
|
affects expression |
ISO |
6 |
42,350,541 |
42,356,748 |
RGD:6480464 |
CTD |
| G |
RT1-DOb |
RT1 class II, locus DOb |
|
affects expression |
ISO |
20 |
4,753,940 |
4,759,648 |
RGD:6480464 |
CTD |
| G |
Rtn2 |
reticulon 2 |
|
affects expression |
ISO |
1 |
78,647,099 |
78,660,389 |
RGD:6480464 |
CTD |
| G |
Rxrg |
retinoid X receptor gamma |
|
affects expression |
ISO |
13 |
83,256,823 |
83,298,724 |
RGD:6480464 |
CTD |
| G |
Saa4 |
serum amyloid A4, constitutive |
|
affects expression |
ISO |
1 |
97,278,427 |
97,282,729 |
RGD:6480464 |
CTD |
| G |
Scarf2 |
scavenger receptor class F, member 2 |
|
affects expression |
ISO |
11 |
85,164,352 |
85,175,734 |
RGD:6480464 |
CTD |
| G |
Scn1b |
sodium channel, voltage-gated, type I, beta |
|
increases expression |
EXP |
1 |
86,162,254 |
86,172,128 |
RGD:6480464 |
CTD |
| G |
Sdf4 |
stromal cell derived factor 4 |
|
affects response to substance |
ISO |
5 |
172,836,094 |
172,853,044 |
RGD:6480464 |
CTD |
| G |
Sec23b |
Sec23 homolog B (S. cerevisiae) |
|
affects expression |
ISO |
3 |
133,104,883 |
133,146,712 |
RGD:6480464 |
CTD |
| G |
Sec24d |
SEC24 family, member D (S. cerevisiae) |
|
affects expression |
ISO |
2 |
219,985,811 |
220,096,797 |
RGD:6480464 |
CTD |
| G |
Sel1l |
sel-1 suppressor of lin-12-like (C. elegans) |
|
affects expression |
ISO |
6 |
115,431,169 |
115,472,901 |
RGD:6480464 |
CTD |
| G |
Sele |
selectin E |
|
decreases expression |
ISO |
13 |
79,813,455 |
79,822,845 |
RGD:6480464 |
CTD |
| G |
Sema4d |
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4D |
|
affects expression |
ISO |
17 |
19,352,632 |
19,373,179 |
RGD:6480464 |
CTD |
| G |
Semg1 |
semenogelin I |
|
affects response to substance |
ISO |
3 |
155,179,283 |
155,182,131 |
RGD:6480464 |
CTD |
| G |
Sept4 |
septin 4 |
|
decreases expression |
EXP |
10 |
75,871,422 |
75,880,878 |
RGD:6480464 |
CTD |
| G |
Serpina5 |
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 5 |
|
affects expression |
ISO |
6 |
128,156,901 |
128,161,334 |
RGD:6480464 |
CTD |
| G |
Serpinb1b |
serine (or cysteine) peptidase inhibitor, clade B, member 1b |
|
affects expression |
ISO |
17 |
37,679,496 |
37,686,875 |
RGD:6480464 |
CTD |
| G |
Serpinb8 |
serpin peptidase inhibitor, clade B (ovalbumin), member 8 |
|
affects expression |
ISO |
13 |
13,718,139 |
13,741,460 |
RGD:6480464 |
CTD |
| G |
Serpinh1 |
serpin peptidase inhibitor, clade H (heat shock protein 47), member 1, (collagen binding protein 1) |
|
affects expression |
ISO |
1 |
156,666,914 |
156,674,210 |
RGD:6480464 |
CTD |
| G |
Sf3b1 |
splicing factor 3b, subunit 1 |
|
affects response to substance |
ISO |
9 |
53,796,176 |
53,837,297 |
RGD:6480464 |
CTD |
| G |
Sfswap |
splicing factor, suppressor of white-apricot homolog (Drosophila) |
|
affects expression |
ISO |
12 |
28,179,091 |
28,249,425 |
RGD:6480464 |
CTD |
| G |
Sgce |
sarcoglycan, epsilon |
|
affects response to substance |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Sh3bgrl3 |
SH3 domain binding glutamic acid-rich protein-like 3 |
|
affects response to substance |
ISO |
5 |
152,877,343 |
152,878,716 |
RGD:6480464 |
CTD |
| G |
Sh3d19 |
SH3 domain containing 19 |
|
affects expression |
ISO |
2 |
178,045,383 |
178,083,708 |
RGD:6480464 |
CTD |
| G |
Shmt1 |
serine hydroxymethyltransferase 1 (soluble) |
|
affects response to substance |
ISO |
10 |
46,936,605 |
46,964,779 |
RGD:6480464 |
CTD |
| G |
Siat7F |
sialyltransferase 7F |
|
affects expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Sigmar1 |
sigma non-opioid intracellular receptor 1 |
|
affects expression |
ISO |
5 |
59,162,537 |
59,165,315 |
RGD:6480464 |
CTD |
| G |
Sirt3 |
sirtuin 3 |
|
affects expression |
ISO |
1 |
201,021,391 |
201,043,756 |
RGD:6480464 |
CTD |
| G |
Skap1 |
src kinase associated phosphoprotein 1 |
|
affects response to substance |
ISO |
10 |
85,193,804 |
85,507,161 |
RGD:6480464 |
CTD |
| G |
Slc10a1 |
solute carrier family 10 (sodium/bile acid cotransporter family), member 1 |
|
decreases expression |
EXP |
6 |
104,735,839 |
104,749,464 |
RGD:6480464 |
CTD |
| G |
Slc12a4 |
solute carrier family 12 (potassium/chloride transporters), member 4 |
|
affects expression |
ISO |
19 |
35,785,181 |
35,807,024 |
RGD:6480464 |
CTD |
| G |
Slc13a2 |
solute carrier family 13 (sodium-dependent dicarboxylate transporter), member 2 |
|
affects expression |
ISO |
10 |
64,503,787 |
64,531,097 |
RGD:6480464 |
CTD |
| G |
Slc16a10 |
solute carrier family 16, member 10 (aromatic amino acid transporter) |
|
affects expression |
ISO |
20 |
44,211,651 |
44,325,332 |
RGD:6480464 |
CTD |
| G |
Slc16a6 |
solute carrier family 16, member 6 (monocarboxylic acid transporter 7) |
|
affects expression |
ISO |
10 |
98,853,289 |
98,875,189 |
RGD:6480464 |
CTD |
| G |
Slc17a6 |
solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 6 |
|
affects expression |
ISO |
1 |
101,425,975 |
101,466,023 |
RGD:6480464 |
CTD |
| G |
Slc19a1 |
solute carrier family 19 (folate transporter), member 1 |
|
multiple interactions |
ISO |
20 |
11,984,283 |
12,001,865 |
RGD:6480464 |
CTD |
| G |
Slc19a1 |
solute carrier family 19 (folate transporter), member 1 |
|
decreases response to substance |
ISO |
20 |
11,984,283 |
12,001,865 |
RGD:6480464 |
CTD |
| G |
Slc19a1 |
solute carrier family 19 (folate transporter), member 1 |
|
affects response to substance |
ISO |
20 |
11,984,283 |
12,001,865 |
RGD:6480464 |
CTD |
| G |
Slc19a1 |
solute carrier family 19 (folate transporter), member 1 |
|
affects response to substance |
ISO |
20 |
11,984,283 |
12,001,865 |
RGD:6480464 |
CTD |
| G |
Slc19a1 |
solute carrier family 19 (folate transporter), member 1 |
|
increases response to substance |
ISO |
20 |
11,984,283 |
12,001,865 |
RGD:6480464 |
CTD |
| G |
Slc19a1 |
solute carrier family 19 (folate transporter), member 1 |
|
multiple interactions |
EXP |
20 |
11,984,283 |
12,001,865 |
RGD:6480464 |
CTD |
| G |
Slc19a1 |
solute carrier family 19 (folate transporter), member 1 |
|
multiple interactions |
EXP |
20 |
11,984,283 |
12,001,865 |
RGD:6480464 |
CTD |
| G |
Slc19a1 |
solute carrier family 19 (folate transporter), member 1 |
|
decreases activity |
EXP |
20 |
11,984,283 |
12,001,865 |
RGD:6480464 |
CTD |
| G |
Slc19a1 |
solute carrier family 19 (folate transporter), member 1 |
|
increases response to substance |
EXP |
20 |
11,984,283 |
12,001,865 |
RGD:6480464 |
CTD |
| G |
Slc19a1 |
solute carrier family 19 (folate transporter), member 1 |
|
increases uptake |
EXP |
20 |
11,984,283 |
12,001,865 |
RGD:6480464 |
CTD |
| G |
Slc19a1 |
solute carrier family 19 (folate transporter), member 1 |
|
affects transport |
EXP |
20 |
11,984,283 |
12,001,865 |
RGD:6480464 |
CTD |
| G |
Slc19a1 |
solute carrier family 19 (folate transporter), member 1 |
|
multiple interactions |
EXP |
20 |
11,984,283 |
12,001,865 |
RGD:6480464 |
CTD |
| G |
Slc19a1 |
solute carrier family 19 (folate transporter), member 1 |
|
increases response to substance |
ISO |
20 |
11,984,283 |
12,001,865 |
RGD:6480464 |
CTD |
| G |
Slc19a1 |
solute carrier family 19 (folate transporter), member 1 |
|
increases transport |
ISO |
20 |
11,984,283 |
12,001,865 |
RGD:6480464 |
CTD |
| G |
Slc19a1 |
solute carrier family 19 (folate transporter), member 1 |
|
multiple interactions |
EXP |
20 |
11,984,283 |
12,001,865 |
RGD:6480464 |
CTD |
| G |
Slc19a1 |
solute carrier family 19 (folate transporter), member 1 |
|
multiple interactions |
EXP |
20 |
11,984,283 |
12,001,865 |
RGD:6480464 |
CTD |
| G |
Slc19a1 |
solute carrier family 19 (folate transporter), member 1 |
|
multiple interactions |
EXP |
20 |
11,984,283 |
12,001,865 |
RGD:6480464 |
CTD |
| G |
Slc19a1 |
solute carrier family 19 (folate transporter), member 1 |
|
increases uptake |
EXP |
20 |
11,984,283 |
12,001,865 |
RGD:6480464 |
CTD |
| G |
Slc19a1 |
solute carrier family 19 (folate transporter), member 1 |
|
increases uptake |
EXP |
20 |
11,984,283 |
12,001,865 |
RGD:6480464 |
CTD |
| G |
Slc19a2 |
solute carrier family 19 (thiamine transporter), member 2 |
|
decreases expression |
EXP |
13 |
80,017,780 |
80,031,777 |
RGD:6480464 |
CTD |
| G |
Slc20a1 |
solute carrier family 20 (phosphate transporter), member 1 |
|
affects expression |
ISO |
3 |
116,813,990 |
116,828,049 |
RGD:6480464 |
CTD |
| G |
Slc22a6 |
solute carrier family 22 (organic anion transporter), member 6 |
|
decreases expression |
EXP |
1 |
211,294,178 |
211,302,398 |
RGD:6480464 |
CTD |
| G |
Slc22a6 |
solute carrier family 22 (organic anion transporter), member 6 |
|
multiple interactions |
EXP |
1 |
211,294,178 |
211,302,398 |
RGD:6480464 |
CTD |
| G |
Slc22a6 |
solute carrier family 22 (organic anion transporter), member 6 |
|
increases uptake |
ISO |
1 |
211,294,178 |
211,302,398 |
RGD:6480464 |
CTD |
| G |
Slc22a7 |
solute carrier family 22 (organic anion transporter), member 7 |
|
increases uptake |
ISO |
9 |
9,934,309 |
9,940,107 |
RGD:6480464 |
CTD |
| G |
Slc22a7 |
solute carrier family 22 (organic anion transporter), member 7 |
|
increases uptake |
ISO |
9 |
9,934,309 |
9,940,107 |
RGD:6480464 |
CTD |
| G |
Slc22a8 |
solute carrier family 22 (organic anion transporter), member 8 |
|
multiple interactions |
EXP |
1 |
211,269,366 |
211,287,596 |
RGD:6480464 |
CTD |
| G |
Slc22a8 |
solute carrier family 22 (organic anion transporter), member 8 |
|
decreases expression |
EXP |
1 |
211,269,366 |
211,287,596 |
RGD:6480464 |
CTD |
| G |
Slc22a8 |
solute carrier family 22 (organic anion transporter), member 8 |
|
affects transport |
ISO |
1 |
211,269,366 |
211,287,596 |
RGD:6480464 |
CTD |
| G |
Slc22a8 |
solute carrier family 22 (organic anion transporter), member 8 |
|
increases uptake |
ISO |
1 |
211,269,366 |
211,287,596 |
RGD:6480464 |
CTD |
| G |
Slc24a6 |
solute carrier family 24 (sodium/lithium/calcium exchanger), member 6 |
|
affects expression |
ISO |
12 |
37,227,844 |
37,250,698 |
RGD:6480464 |
CTD |
| G |
Slc25a1 |
solute carrier family 25 (mitochondrial carrier, citrate transporter), member 1 |
|
affects expression |
ISO |
11 |
85,043,902 |
85,046,919 |
RGD:6480464 |
CTD |
| G |
Slc25a28 |
solute carrier family 25 (mitochondrial iron transporter), member 28 |
|
affects expression |
ISO |
1 |
247,159,998 |
247,171,232 |
RGD:6480464 |
CTD |
| G |
Slc26a2 |
solute carrier family 26 (sulfate transporter), member 2 |
|
affects response to substance |
ISO |
18 |
57,170,814 |
57,184,489 |
RGD:6480464 |
CTD |
| G |
Slc27a2 |
solute carrier family 27 (fatty acid transporter), member 2 |
|
affects response to substance |
ISO |
3 |
114,072,570 |
114,114,269 |
RGD:6480464 |
CTD |
| G |
Slc27a2 |
solute carrier family 27 (fatty acid transporter), member 2 |
|
affects expression |
ISO |
3 |
114,072,570 |
114,114,269 |
RGD:6480464 |
CTD |
| G |
Slc2a3 |
solute carrier family 2 (facilitated glucose transporter), member 3 |
|
affects expression |
ISO |
4 |
159,210,116 |
159,221,169 |
RGD:6480464 |
CTD |
| G |
Slc35a4 |
solute carrier family 35, member A4 |
|
affects expression |
ISO |
18 |
29,318,679 |
29,321,847 |
RGD:6480464 |
CTD |
| G |
Slc37a1 |
solute carrier family 37 (glycerol-3-phosphate transporter), member 1 |
|
affects expression |
ISO |
20 |
9,689,661 |
9,745,102 |
RGD:6480464 |
CTD |
| G |
Slc37a4 |
solute carrier family 37 (glucose-6-phosphate transporter), member 4 |
|
affects expression |
ISO |
8 |
47,363,896 |
47,369,981 |
RGD:6480464 |
CTD |
| G |
Slc38a4 |
solute carrier family 38, member 4 |
|
affects expression |
ISO |
7 |
135,693,013 |
135,750,703 |
RGD:6480464 |
CTD |
| G |
Slc39a10 |
solute carrier family 39 (zinc transporter), member 10 |
|
affects expression |
ISO |
9 |
52,168,107 |
52,217,677 |
RGD:6480464 |
CTD |
| G |
Slc39a11 |
solute carrier family 39 (metal ion transporter), member 11 |
|
affects expression |
ISO |
10 |
102,863,399 |
103,189,081 |
RGD:6480464 |
CTD |
| G |
Slc39a8 |
solute carrier family 39 (zinc transporter), member 8 |
|
affects expression |
ISO |
2 |
233,340,397 |
233,403,461 |
RGD:6480464 |
CTD |
| G |
Slc3a2 |
solute carrier family 3 (activators of dibasic and neutral amino acid transport), member 2 |
|
increases expression |
EXP |
1 |
211,375,889 |
211,390,313 |
RGD:6480464 |
CTD |
| G |
Slc46a1 |
solute carrier family 46 (folate transporter), member 1 |
|
multiple interactions |
ISO |
10 |
64,576,068 |
64,582,504 |
RGD:6480464 |
CTD |
| G |
Slc46a1 |
solute carrier family 46 (folate transporter), member 1 |
|
decreases activity |
ISO |
10 |
64,576,068 |
64,582,504 |
RGD:6480464 |
CTD |
| G |
Slc46a1 |
solute carrier family 46 (folate transporter), member 1 |
|
increases transport |
ISO |
10 |
64,576,068 |
64,582,504 |
RGD:6480464 |
CTD |
| G |
Slc46a1 |
solute carrier family 46 (folate transporter), member 1 |
|
increases transport |
EXP |
10 |
64,576,068 |
64,582,504 |
RGD:6480464 |
CTD |
| G |
Slc46a1 |
solute carrier family 46 (folate transporter), member 1 |
|
increases transport |
ISO |
10 |
64,576,068 |
64,582,504 |
RGD:6480464 |
CTD |
| G |
Slc52a2 |
solute carrier family 52, riboflavin transporter, member 2 |
|
affects response to substance |
ISO |
7 |
114,590,752 |
114,594,162 |
RGD:6480464 |
CTD |
| G |
Slc5a4b |
solute carrier family 5 (neutral amino acid transporters, system A), member 4b |
|
affects expression |
ISO |
20 |
12,960,558 |
13,006,358 |
RGD:6480464 |
CTD |
| G |
Slc5a6 |
solute carrier family 5 (sodium-dependent vitamin transporter), member 6 |
|
affects expression |
ISO |
6 |
25,301,630 |
25,312,901 |
RGD:6480464 |
CTD |
| G |
Slc6a9 |
solute carrier family 6 (neurotransmitter transporter, glycine), member 9 |
|
affects expression |
ISO |
5 |
138,300,869 |
138,334,893 |
RGD:6480464 |
CTD |
| G |
Slc9a9 |
solute carrier family 9, subfamily A (NHE9, cation proton antiporter 9), member 9 |
|
affects expression |
ISO |
8 |
99,736,831 |
100,324,858 |
RGD:6480464 |
CTD |
| G |
Slfn13 |
schlafen family member 13 |
|
affects expression |
ISO |
10 |
71,192,184 |
71,205,605 |
RGD:6480464 |
CTD |
| G |
Slmo2 |
slowmo homolog 2 (Drosophila) |
|
affects response to substance |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Smad7 |
SMAD family member 7 |
|
affects expression |
ISO |
18 |
72,294,803 |
72,323,354 |
RGD:6480464 |
CTD |
| G |
Smc4 |
structural maintenance of chromosomes 4 |
|
affects expression |
ISO |
2 |
158,987,318 |
159,015,705 |
RGD:6480464 |
CTD |
| G |
Smo |
smoothened, frizzled family receptor |
|
affects expression |
ISO |
4 |
56,623,494 |
56,645,571 |
RGD:6480464 |
CTD |
| G |
Smpd3 |
sphingomyelin phosphodiesterase 3, neutral membrane |
|
affects expression |
ISO |
19 |
36,112,166 |
36,195,564 |
RGD:6480464 |
CTD |
| G |
Smtn |
smoothelin |
|
affects expression |
ISO |
14 |
84,160,580 |
84,182,869 |
RGD:6480464 |
CTD |
| G |
Snap29 |
synaptosomal-associated protein 29 |
|
affects expression |
ISO |
11 |
85,579,141 |
85,609,842 |
RGD:6480464 |
CTD |
| G |
Snx17 |
sorting nexin 17 |
|
affects expression |
ISO |
6 |
25,153,586 |
25,159,556 |
RGD:6480464 |
CTD |
| G |
Snx19 |
sorting nexin 19 |
|
affects expression |
ISO |
8 |
30,149,376 |
30,186,285 |
RGD:6480464 |
CTD |
| G |
Sorcs3 |
sortilin-related VPS10 domain containing receptor 3 |
|
affects expression |
ISO |
1 |
254,125,935 |
254,345,330 |
RGD:6480464 |
CTD |
| G |
Sort1 |
sortilin 1 |
|
affects expression |
ISO |
2 |
203,853,009 |
203,931,559 |
RGD:6480464 |
CTD |
| G |
Sp3 |
Sp3 transcription factor |
|
affects expression |
ISO |
3 |
55,440,985 |
55,485,768 |
RGD:6480464 |
CTD |
| G |
Spata5 |
spermatogenesis associated 5 |
|
affects expression |
ISO |
2 |
123,962,875 |
124,154,127 |
RGD:6480464 |
CTD |
| G |
Spg20 |
spastic paraplegia 20 (Troyer syndrome) |
|
affects response to substance |
ISO |
2 |
144,335,236 |
144,362,246 |
RGD:6480464 |
CTD |
| G |
Spg7 |
spastic paraplegia 7 homolog (human) |
|
affects expression |
ISO |
19 |
53,400,904 |
53,433,742 |
RGD:6480464 |
CTD |
| G |
Spon2 |
spondin 2, extracellular matrix protein |
|
affects expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Sprr4 |
small proline-rich protein 4 |
|
affects expression |
ISO |
2 |
185,492,074 |
185,492,307 |
RGD:6480464 |
CTD |
| G |
Spry4 |
sprouty homolog 4 (Drosophila) |
|
affects expression |
ISO |
18 |
31,532,680 |
31,547,586 |
RGD:6480464 |
CTD |
| G |
Sptlc2 |
serine palmitoyltransferase, long chain base subunit 2 |
|
affects expression |
ISO |
6 |
111,546,037 |
111,622,959 |
RGD:6480464 |
CTD |
| G |
Src |
v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian) |
|
affects expression |
ISO |
3 |
148,157,256 |
148,170,524 |
RGD:6480464 |
CTD |
| G |
Sri |
sorcin |
|
affects expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Srm |
spermidine synthase |
|
affects expression |
ISO |
5 |
165,672,516 |
165,675,673 |
RGD:6480464 |
CTD |
| G |
Srr |
serine racemase |
|
affects expression |
ISO |
10 |
62,217,481 |
62,234,831 |
RGD:6480464 |
CTD |
| G |
Srsf1 |
serine/arginine-rich splicing factor 1 |
|
affects expression |
ISO |
10 |
76,339,824 |
76,344,552 |
RGD:6480464 |
CTD |
| G |
St3gal1 |
ST3 beta-galactoside alpha-2,3-sialyltransferase 1 |
|
affects expression |
ISO |
7 |
104,467,678 |
104,474,345 |
RGD:6480464 |
CTD |
| G |
St3gal5 |
ST3 beta-galactoside alpha-2,3-sialyltransferase 5 |
|
affects expression |
ISO |
4 |
105,373,385 |
105,432,192 |
RGD:6480464 |
CTD |
| G |
Stk10 |
serine/threonine kinase 10 |
|
affects expression |
ISO |
10 |
17,379,245 |
17,481,768 |
RGD:6480464 |
CTD |
| G |
Stk38 |
serine/threonine kinase 38 |
|
affects expression |
ISO |
20 |
7,257,546 |
7,264,441 |
RGD:6480464 |
CTD |
| G |
Styx |
serine/threonine/tyrosine interacting protein |
|
affects expression |
ISO |
15 |
21,241,269 |
21,257,477 |
RGD:6480464 |
CTD |
| G |
Styxl2 |
serine/threonine/tyrosine interacting protein-like2 |
|
affects expression |
ISO |
7 |
60,137,562 |
60,138,233 |
RGD:6480464 |
CTD |
| G |
Suclg2 |
succinate-CoA ligase, GDP-forming, beta subunit |
|
affects response to substance |
ISO |
4 |
129,995,856 |
130,276,182 |
RGD:6480464 |
CTD |
| G |
Sucnr1 |
succinate receptor 1 |
|
affects expression |
ISO |
2 |
149,416,068 |
149,417,021 |
RGD:6480464 |
CTD |
| G |
Sulf1 |
sulfatase 1 |
|
affects expression |
ISO |
5 |
5,582,896 |
5,748,106 |
RGD:6480464 |
CTD |
| G |
Sult1a1 |
sulfotransferase family, cytosolic, 1A, phenol-preferring, member 1 |
|
affects expression |
ISO |
1 |
185,829,205 |
185,832,725 |
RGD:6480464 |
CTD |
| G |
Sult4a1 |
sulfotransferase family 4A, member 1 |
|
affects expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Sun5 |
Sad1 and UNC84 domain containing 5 |
|
affects expression |
ISO |
3 |
144,236,963 |
144,257,526 |
RGD:6480464 |
CTD |
| G |
Sycp3 |
synaptonemal complex protein 3 |
|
affects expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Syt2 |
synaptotagmin II |
|
affects expression |
ISO |
13 |
47,690,518 |
47,699,094 |
RGD:6480464 |
CTD |
| G |
Taf12 |
TAF12 RNA polymerase II, TATA box binding protein (TBP)-associated factor |
|
affects expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Taf5 |
TAF5 RNA polymerase II, TATA box binding protein (TBP)-associated factor |
|
affects expression |
ISO |
1 |
252,391,049 |
252,406,534 |
RGD:6480464 |
CTD |
| G |
Tagln |
transgelin |
|
decreases expression |
ISO |
8 |
48,902,208 |
48,907,682 |
RGD:6480464 |
CTD |
| G |
Tagln |
transgelin |
|
decreases expression |
ISO |
8 |
48,902,208 |
48,907,682 |
RGD:6480464 |
CTD |
| G |
Tas1r1 |
taste receptor, type 1, member 1 |
|
affects expression |
ISO |
5 |
169,256,281 |
169,268,006 |
RGD:6480464 |
CTD |
| G |
Tas2r108 |
taste receptor, type 2, member 108 |
|
affects expression |
ISO |
4 |
68,048,215 |
68,049,129 |
RGD:6480464 |
CTD |
| G |
Tbx6 |
T-box 6 |
|
affects expression |
ISO |
1 |
185,957,068 |
185,960,977 |
RGD:6480464 |
CTD |
| G |
Tcf12 |
transcription factor 12 |
|
affects response to substance |
ISO |
8 |
76,311,327 |
76,498,091 |
RGD:6480464 |
CTD |
| G |
Tcn2 |
transcobalamin 2 |
|
affects metabolic processing |
ISO |
14 |
84,579,191 |
84,593,641 |
RGD:6480464 |
CTD |
| G |
Tcp1 |
t-complex 1 |
|
affects expression |
ISO |
1 |
42,103,543 |
42,111,222 |
RGD:6480464 |
CTD |
| G |
Tec |
tec protein tyrosine kinase |
|
affects expression |
ISO |
14 |
37,756,486 |
37,865,180 |
RGD:6480464 |
CTD |
| G |
Tek |
TEK tyrosine kinase, endothelial |
|
affects expression |
ISO |
5 |
115,047,195 |
115,196,172 |
RGD:6480464 |
CTD |
| G |
Tesk1 |
testis-specific kinase 1 |
|
affects expression |
ISO |
5 |
59,913,793 |
59,918,422 |
RGD:6480464 |
CTD |
| G |
Tex9 |
testis expressed 9 |
|
affects expression |
ISO |
8 |
77,044,217 |
77,080,749 |
RGD:6480464 |
CTD |
| G |
Tfap2a |
transcription factor AP-2 alpha |
|
affects expression |
ISO |
17 |
30,017,580 |
30,034,852 |
RGD:6480464 |
CTD |
| G |
Tfcp2 |
transcription factor CP2 |
|
affects expression |
ISO |
7 |
139,254,024 |
139,295,978 |
RGD:6480464 |
CTD |
| G |
Tfpi2 |
tissue factor pathway inhibitor 2 |
|
affects expression |
ISO |
4 |
28,807,080 |
28,811,502 |
RGD:6480464 |
CTD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
affects response to substance |
ISO |
1 |
80,894,705 |
80,911,020 |
RGD:6480464 |
CTD |
| G |
Tgif2-ps1 |
TGFB-induced factor homeobox 2, pseudogene 1 |
|
affects expression |
ISO |
17 |
54,809,429 |
54,810,142 |
RGD:6480464 |
CTD |
| G |
Tgs1 |
trimethylguanosine synthase 1 |
|
affects expression |
ISO |
5 |
16,818,391 |
16,851,916 |
RGD:6480464 |
CTD |
| G |
Thbd |
thrombomodulin |
|
affects expression |
ISO |
3 |
137,158,955 |
137,162,607 |
RGD:6480464 |
CTD |
| G |
Thrsp |
thyroid hormone responsive |
|
affects expression |
ISO |
1 |
154,647,339 |
154,651,663 |
RGD:6480464 |
CTD |
| G |
Tjp3 |
tight junction protein 3 |
|
affects expression |
ISO |
7 |
9,917,359 |
9,930,081 |
RGD:6480464 |
CTD |
| G |
Tktl1 |
transketolase-like 1 |
|
affects expression |
ISO |
X |
160,144,916 |
160,177,852 |
RGD:6480464 |
CTD |
| G |
Tle1 |
transducin-like enhancer of split 1 (E(sp1) homolog, Drosophila) |
|
affects response to substance |
ISO |
5 |
89,682,837 |
89,765,682 |
RGD:6480464 |
CTD |
| G |
Tll2 |
tolloid-like 2 |
|
affects expression |
ISO |
1 |
246,259,524 |
246,406,825 |
RGD:6480464 |
CTD |
| G |
Tln1 |
talin 1 |
|
affects response to substance |
ISO |
5 |
60,010,952 |
60,040,908 |
RGD:6480464 |
CTD |
| G |
Tlr4 |
toll-like receptor 4 |
|
affects expression |
ISO |
5 |
83,564,100 |
83,577,735 |
RGD:6480464 |
CTD |
| G |
Tmc4 |
transmembrane channel-like 4 |
|
affects expression |
ISO |
1 |
63,852,716 |
63,864,605 |
RGD:6480464 |
CTD |
| G |
Tmeff1 |
transmembrane protein with EGF-like and two follistatin-like domains 1 |
|
affects response to substance |
ISO |
5 |
65,271,278 |
65,357,296 |
RGD:6480464 |
CTD |
| G |
Tmie |
transmembrane inner ear |
|
affects expression |
ISO |
8 |
115,254,502 |
115,269,123 |
RGD:6480464 |
CTD |
| G |
Tmprss4 |
transmembrane protease, serine 4 |
|
affects expression |
ISO |
8 |
48,120,501 |
48,154,809 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
increases expression |
EXP |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
EXP |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
EXP |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
affects expression |
EXP |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnfrsf10b |
tumor necrosis factor receptor superfamily, member 10b |
|
increases expression |
ISO |
15 |
50,138,439 |
50,163,254 |
RGD:6480464 |
CTD |
| G |
Tnfrsf11b |
tumor necrosis factor receptor superfamily, member 11b |
|
increases secretion |
ISO |
7 |
90,606,424 |
90,634,431 |
RGD:6480464 |
CTD |
| G |
Tnfsf11 |
tumor necrosis factor (ligand) superfamily, member 11 |
|
decreases expression |
ISO |
15 |
59,397,837 |
59,428,014 |
RGD:6480464 |
CTD |
| G |
Tnp1 |
transition protein 1 |
|
affects expression |
ISO |
9 |
72,397,750 |
72,398,359 |
RGD:6480464 |
CTD |
| G |
Tnpo2 |
transportin 2 |
|
affects expression |
ISO |
19 |
24,755,689 |
24,775,599 |
RGD:6480464 |
CTD |
| G |
Tob1 |
transducer of ErbB-2.1 |
|
affects response to substance |
ISO |
10 |
82,852,405 |
82,854,443 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
multiple interactions |
ISO |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
increases expression |
ISO |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
multiple interactions |
ISO |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
increases response to substance |
ISO |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
multiple interactions |
ISO |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
increases expression |
EXP |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
multiple interactions |
EXP |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Traip |
TRAF-interacting protein |
|
affects expression |
ISO |
8 |
113,220,855 |
113,240,631 |
RGD:6480464 |
CTD |
| G |
Trim24 |
tripartite motif-containing 24 |
|
affects expression |
ISO |
4 |
65,490,076 |
65,543,305 |
RGD:6480464 |
CTD |
| G |
Trim28 |
tripartite motif-containing 28 |
|
affects response to substance |
ISO |
1 |
72,892,399 |
72,899,070 |
RGD:6480464 |
CTD |
| G |
Trim7 |
tripartite motif-containing 7 |
|
affects expression |
ISO |
10 |
34,099,610 |
34,118,055 |
RGD:6480464 |
CTD |
| G |
Trpm5 |
transient receptor potential cation channel, subfamily M, member 5 |
|
affects expression |
ISO |
1 |
203,347,410 |
203,364,520 |
RGD:6480464 |
CTD |
| G |
Tsga13 |
testis specific, 13 |
|
affects expression |
ISO |
4 |
57,958,452 |
57,979,580 |
RGD:6480464 |
CTD |
| G |
Tspan4 |
tetraspanin 4 |
|
affects response to substance |
ISO |
1 |
201,661,391 |
201,681,042 |
RGD:6480464 |
CTD |
| G |
Tspan4 |
tetraspanin 4 |
|
affects expression |
ISO |
1 |
201,661,391 |
201,681,042 |
RGD:6480464 |
CTD |
| G |
Ttf2 |
transcription termination factor, RNA polymerase II |
|
affects response to substance |
ISO |
2 |
196,016,515 |
196,018,882 |
RGD:6480464 |
CTD |
| G |
Ttl |
tubulin tyrosine ligase |
|
affects expression |
ISO |
3 |
116,671,419 |
116,697,989 |
RGD:6480464 |
CTD |
| G |
Ttr |
transthyretin |
|
decreases expression |
EXP |
18 |
12,406,571 |
12,413,680 |
RGD:6480464 |
CTD |
| G |
Tyk2 |
tyrosine kinase 2 |
|
affects response to substance |
ISO |
8 |
20,096,969 |
20,149,004 |
RGD:6480464 |
CTD |
| G |
Tyms |
thymidylate synthetase |
|
affects response to substance |
ISO |
9 |
112,604,912 |
112,617,706 |
RGD:6480464 |
CTD |
| G |
Tyms |
thymidylate synthetase |
|
decreases response to substance |
ISO |
9 |
112,604,912 |
112,617,706 |
RGD:6480464 |
CTD |
| G |
Tyms |
thymidylate synthetase |
|
affects response to substance |
ISO |
9 |
112,604,912 |
112,617,706 |
RGD:6480464 |
CTD |
| G |
Tyms |
thymidylate synthetase |
|
increases response to substance |
ISO |
9 |
112,604,912 |
112,617,706 |
RGD:6480464 |
CTD |
| G |
Tyms |
thymidylate synthetase |
|
increases response to substance |
ISO |
9 |
112,604,912 |
112,617,706 |
RGD:6480464 |
CTD |
| G |
Tyms |
thymidylate synthetase |
|
increases expression |
EXP |
9 |
112,604,912 |
112,617,706 |
RGD:6480464 |
CTD |
| G |
Tyro3 |
TYRO3 protein tyrosine kinase |
|
affects expression |
ISO |
3 |
106,309,671 |
106,328,607 |
RGD:6480464 |
CTD |
| G |
Uba1 |
ubiquitin-like modifier activating enzyme 1 |
|
affects response to substance |
ISO |
X |
12,926,049 |
12,944,522 |
RGD:6480464 |
CTD |
| G |
Ube2c |
ubiquitin-conjugating enzyme E2C |
|
decreases expression |
ISO |
3 |
155,800,357 |
155,802,757 |
RGD:6480464 |
CTD |
| G |
Ube2j2 |
ubiquitin-conjugating enzyme E2, J2 |
|
affects expression |
ISO |
5 |
172,782,311 |
172,796,727 |
RGD:6480464 |
CTD |
| G |
Ucn3 |
urocortin 3 |
|
affects expression |
ISO |
17 |
77,482,852 |
77,488,471 |
RGD:6480464 |
CTD |
| G |
Ugcg |
UDP-glucose ceramide glucosyltransferase |
|
affects response to substance |
ISO |
5 |
77,263,334 |
77,295,794 |
RGD:6480464 |
CTD |
| G |
Ugt1a1 |
UDP glucuronosyltransferase 1 family, polypeptide A1 |
|
increases expression |
ISO |
9 |
87,091,241 |
87,098,362 |
RGD:6480464 |
CTD |
| G |
Ugt1a6 |
UDP glucuronosyltransferase 1 family, polypeptide A6 |
|
decreases response to substance |
ISO |
9 |
87,037,154 |
87,098,362 |
RGD:6480464 |
CTD |
| G |
Ugt1a6 |
UDP glucuronosyltransferase 1 family, polypeptide A6 |
|
increases expression |
ISO |
9 |
87,037,154 |
87,098,362 |
RGD:6480464 |
CTD |
| G |
Ugt1a8 |
UDP glycosyltransferase 1 family, polypeptide A8 |
|
decreases expression |
ISO |
9 |
87,017,029 |
87,098,362 |
RGD:6480464 |
CTD |
| G |
Ugt1a9 |
UDP glucuronosyltransferase 1 family, polypeptide A9 |
|
decreases expression |
ISO |
9 |
86,986,915 |
87,098,362 |
RGD:6480464 |
CTD |
| G |
Unc119 |
UNC-119 homolog (C. elegans) |
|
affects expression |
ISO |
10 |
64,285,993 |
64,291,392 |
RGD:6480464 |
CTD |
| G |
Ung |
uracil-DNA glycosylase |
|
affects expression |
ISO |
12 |
43,520,629 |
43,528,873 |
RGD:6480464 |
CTD |
| G |
Unk |
unkempt homolog (Drosophila) |
|
affects expression |
ISO |
10 |
106,139,489 |
106,169,639 |
RGD:6480464 |
CTD |
| G |
Upk3a |
uroplakin 3A |
|
affects expression |
ISO |
7 |
123,032,773 |
123,037,846 |
RGD:6480464 |
CTD |
| G |
Uqcr11 |
ubiquinol-cytochrome c reductase, complex III subunit XI |
|
affects response to substance |
ISO |
7 |
10,816,422 |
10,821,051 |
RGD:6480464 |
CTD |
| G |
Ush1c |
Usher syndrome 1C |
|
affects response to substance |
ISO |
1 |
96,720,185 |
96,768,550 |
RGD:6480464 |
CTD |
| G |
Usp18 |
ubiquitin specific peptidase 18 |
|
affects expression |
ISO |
4 |
157,692,720 |
157,694,884 |
RGD:6480464 |
CTD |
| G |
Usp2 |
ubiquitin specific peptidase 2 |
|
affects expression |
ISO |
8 |
47,052,085 |
47,076,321 |
RGD:6480464 |
CTD |
| G |
Uts2 |
urotensin 2 |
|
affects expression |
ISO |
5 |
168,143,315 |
168,148,700 |
RGD:6480464 |
CTD |
| G |
Vasn |
vasorin |
|
affects expression |
ISO |
10 |
11,047,084 |
11,057,591 |
RGD:6480464 |
CTD |
| G |
Vav3 |
vav 3 guanine nucleotide exchange factor |
|
affects expression |
ISO |
2 |
204,982,222 |
205,326,505 |
RGD:6480464 |
CTD |
| G |
Vdr |
vitamin D (1,25- dihydroxyvitamin D3) receptor |
|
affects response to substance |
ISO |
7 |
136,567,614 |
136,617,280 |
RGD:6480464 |
CTD |
| G |
Vipr1 |
vasoactive intestinal peptide receptor 1 |
|
affects expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Vkorc1l1 |
vitamin K epoxide reductase complex, subunit 1-like 1 |
|
affects expression |
ISO |
12 |
27,764,873 |
27,813,093 |
RGD:6480464 |
CTD |
| G |
Vldlr |
very low density lipoprotein receptor |
|
affects expression |
ISO |
1 |
230,666,736 |
230,697,748 |
RGD:6480464 |
CTD |
| G |
Vnn1 |
vanin 1 |
|
affects expression |
ISO |
1 |
22,087,290 |
22,097,592 |
RGD:6480464 |
CTD |
| G |
Wdfy3 |
WD repeat and FYVE domain containing 3 |
|
affects expression |
ISO |
14 |
8,916,412 |
9,060,345 |
RGD:6480464 |
CTD |
| G |
Wdr1 |
WD repeat domain 1 |
|
affects expression |
ISO |
14 |
77,489,828 |
77,524,430 |
RGD:6480464 |
CTD |
| G |
Wdr18 |
WD repeat domain 18 |
|
affects response to substance |
ISO |
7 |
11,253,373 |
11,261,805 |
RGD:6480464 |
CTD |
| G |
Wdr3 |
WD repeat domain 3 |
|
affects response to substance |
ISO |
2 |
195,093,948 |
195,116,591 |
RGD:6480464 |
CTD |
| G |
Wisp1 |
WNT1 inducible signaling pathway protein 1 |
|
decreases expression |
ISO |
7 |
104,263,089 |
104,291,621 |
RGD:6480464 |
CTD |
| G |
Wnk4 |
WNK lysine deficient protein kinase 4 |
|
affects expression |
ISO |
10 |
90,289,273 |
90,306,225 |
RGD:6480464 |
CTD |
| G |
Wnt10b |
wingless-type MMTV integration site family, member 10B |
|
affects expression |
ISO |
7 |
137,541,197 |
137,547,000 |
RGD:6480464 |
CTD |
| G |
Wnt2b |
wingless-type MMTV integration site family, member 2B |
|
affects expression |
ISO |
2 |
200,218,630 |
200,233,002 |
RGD:6480464 |
CTD |
| G |
Wnt5a |
wingless-type MMTV integration site family, member 5A |
|
increases expression |
ISO |
16 |
3,782,025 |
3,799,625 |
RGD:6480464 |
CTD |
| G |
Xab2 |
XPA binding protein 2 |
|
affects expression |
ISO |
12 |
2,533,687 |
2,545,690 |
RGD:6480464 |
CTD |
| G |
Xpnpep2 |
X-prolyl aminopeptidase (aminopeptidase P) 2, membrane-bound |
|
affects expression |
ISO |
X |
134,474,960 |
134,501,782 |
RGD:6480464 |
CTD |
| G |
Xrcc5 |
X-ray repair complementing defective repair in Chinese hamster cells 5 |
|
affects expression |
ISO |
9 |
71,472,459 |
71,581,936 |
RGD:6480464 |
CTD |
| G |
Zeb1 |
zinc finger E-box binding homeobox 1 |
|
affects expression |
ISO |
17 |
60,177,150 |
60,198,584 |
RGD:6480464 |
CTD |
| G |
Zfp189 |
zinc finger protein 189 |
|
increases expression |
EXP |
5 |
66,266,848 |
66,278,203 |
RGD:6480464 |
CTD |
| G |
Zfp192 |
zinc finger protein 192 |
|
affects expression |
ISO |
17 |
50,686,109 |
50,693,383 |
RGD:6480464 |
CTD |
| G |
Zfp27 |
zinc finger protein 27 |
|
affects expression |
ISO |
1 |
84,910,957 |
84,914,508 |
RGD:6480464 |
CTD |
| G |
Zfp330 |
zinc finger protein 330 |
|
affects expression |
ISO |
19 |
27,048,575 |
27,059,878 |
RGD:6480464 |
CTD |
| G |
Zfp354c |
zinc finger protein 354C |
|
affects expression |
ISO |
10 |
36,387,210 |
36,398,223 |
RGD:6480464 |
CTD |
| G |
Zfp40 |
zinc finger protein 40 |
|
affects expression |
ISO |
1 |
61,142,452 |
61,164,961 |
RGD:6480464 |
CTD |
| G |
Zfp52 |
zinc finger protein 52 |
|
affects expression |
ISO |
1 |
59,540,774 |
59,568,607 |
RGD:6480464 |
CTD |
| G |
Zfp580 |
zinc finger protein 580 |
|
affects response to substance |
ISO |
1 |
67,525,765 |
67,527,928 |
RGD:6480464 |
CTD |
| G |
Zfp612 |
zinc finger protein 612 |
|
affects expression |
ISO |
19 |
39,961,602 |
39,975,049 |
RGD:6480464 |
CTD |
| G |
Zfp719 |
zinc finger protein 719 |
|
affects response to substance |
ISO |
1 |
93,986,011 |
93,992,829 |
RGD:6480464 |
CTD |
| G |
Zfp819 |
zinc finger protein 819 |
|
affects response to substance |
ISO |
1 |
94,009,048 |
94,019,562 |
RGD:6480464 |
CTD |
| G |
Zfp84 |
zinc finger protein 84 |
|
affects expression |
ISO |
1 |
84,777,391 |
84,792,946 |
RGD:6480464 |
CTD |
| G |
Zfpn1a4 |
zinc finger protein, subfamily 1A, 4 (Eos) |
|
affects expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Zmym3 |
zinc finger, MYM-type 3 |
|
affects expression |
ISO |
X |
89,476,632 |
89,491,430 |
RGD:6480464 |
CTD |
Term paths to the root
|